AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|38177564|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|All other|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|16|191951502|Female|All other|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|191951502|Female|All other|2006-2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|39682297|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|44|38177564|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|38305772|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|38466303|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Anaplastic astrocytoma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|154|191951502|Female|Anaplastic astrocytoma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|39682297|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|39875033|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|39970215|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|39544072|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Anaplastic oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|191951502|Female|Anaplastic oligodendroglioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|38177564|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|38305772|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|38466303|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Astrocytoma, NOS|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Malignant|411|191951502|Female|Astrocytoma, NOS|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|39682297|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|39875033|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|39970215|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|39544072|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|38177564|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38177564|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|38305772|Female|Choroid plexus|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|38305772|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|38466303|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38466303|Female|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|146|191951502|Female|Choroid plexus|2006-2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|37|191951502|Female|Choroid plexus|2006-2010|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|39682297|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39682297|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|39875033|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39875033|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39970215|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39970215|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|39544072|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39544072|Female|Choroid plexus|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|77|38177564|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38177564|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|73|38305772|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38305772|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|38466303|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38466303|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|382|191951502|Female|Craniopharyngioma|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|191951502|Female|Craniopharyngioma|2006-2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|39682297|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39682297|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|60|39875033|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39875033|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|39970215|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39970215|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|39544072|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39544072|Female|Craniopharyngioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|38177564|Female|Diffuse astrocytoma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|38305772|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Diffuse astrocytoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|83|191951502|Female|Diffuse astrocytoma|2006-2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39682297|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|39875033|Female|Diffuse astrocytoma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39970215|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|39544072|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|208|38177564|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.4|Malignant|171|38305772|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|38466303|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
0-19|0.5|0.6|0.5|Malignant|986|191951502|Female|Embryonal/primitive/medulloblastoma|2006-2010|0.5|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.6|Malignant|218|39682297|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|229|39875033|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|197|39970215|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|39544072|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|55|191951502|Female|Ependymoma variants|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|191951502|Female|Ependymoma variants|2006-2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|38177564|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|103|38305772|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|38466303|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Ependymoma/anaplastic ependymoma|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Malignant|384|191951502|Female|Ependymoma/anaplastic ependymoma|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|39682297|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|39875033|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|78|39970215|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|39544072|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|38177564|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|43|38305772|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Germ Cell Tumors|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|38466303|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|78|191951502|Female|Germ Cell Tumors|2006-2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|167|191951502|Female|Germ Cell Tumors|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|39682297|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|39875033|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|26|39875033|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|20|39970215|Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|42|39970215|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Germ Cell Tumors|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39544072|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|38177564|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|38305772|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|41|38466303|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Glioblastoma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|242|191951502|Female|Glioblastoma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|60|39682297|Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|61|39875033|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|39970215|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|39544072|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|225|38177564|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|222|38305772|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|234|38466303|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|29|191951502|Female|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|1206|191951502|Female|Glioma malignant, NOS|2006-2010|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|253|39682297|Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|253|39875033|Female|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|278|39970215|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|217|39544072|Female|Glioma malignant, NOS|2010|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|38305772|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|38305772|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|50|191951502|Female|Hemangioblastoma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|191951502|Female|Hemangioblastoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39682297|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39682297|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|38305772|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38305772|Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|38466303|Female|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38466303|Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|160|191951502|Female|Hemangioma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|191951502|Female|Hemangioma|2006-2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39682297|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39682297|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|39875033|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39875033|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|39970215|Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39970215|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|39544072|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39544072|Female|Hemangioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Local Extensions from Regional Tumors|2006-2010|~|~|~
0-19|~|~|~|Malignant|~|191951502|Female|Local Extensions from Regional Tumors|2006-2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|191951502|Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|38177564|Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|38177564|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|38305772|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38305772|Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|38466303|Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|38466303|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|260|191951502|Female|Meningioma|2006-2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|191951502|Female|Meningioma|2006-2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|39682297|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39682297|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|39875033|Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39875033|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|39970215|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39970215|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|39544072|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39544072|Female|Meningioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|38177564|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Mixed glioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|73|191951502|Female|Mixed glioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|39682297|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39875033|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|39544072|Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|31|38177564|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|38177564|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|50|38305772|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|38305772|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|46|38466303|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|38466303|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|281|191951502|Female|Neoplasm, unspecified|2006-2010|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|82|191951502|Female|Neoplasm, unspecified|2006-2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|44|39682297|Female|Neoplasm, unspecified|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|39682297|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|68|39875033|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|39875033|Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|39970215|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|39970215|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|73|39544072|Female|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39544072|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|38177564|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38177564|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|139|38305772|Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|38305772|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|38466303|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|38466303|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|527|191951502|Female|Nerve sheath, benign and malignant|2006-2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|191951502|Female|Nerve sheath, benign and malignant|2006-2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|39682297|Female|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39682297|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|117|39875033|Female|Nerve sheath, benign and malignant|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|39875033|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|39970215|Female|Nerve sheath, benign and malignant|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39970215|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|39544072|Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39544072|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Neuroepithelial|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|29|191951502|Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|39875033|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Neuroepithelial|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|110|38177564|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|38177564|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|128|38305772|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|38305772|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|114|38466303|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|38466303|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|612|191951502|Female|Neuronal/glial, neuronal|2006-2010|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|112|191951502|Female|Neuronal/glial, neuronal|2006-2010|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|130|39682297|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|30|39682297|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|125|39875033|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39875033|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|125|39970215|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39970215|Female|Neuronal/glial, neuronal|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|39544072|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|21|39544072|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|38177564|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|38305772|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|38466303|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|102|191951502|Female|Oligodendroglioma|2006-2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|39682297|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39875033|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39544072|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Other mesenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|38466303|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|38466303|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|84|191951502|Female|Other mesenchymal|2006-2010|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|34|191951502|Female|Other mesenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|16|39682297|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39682297|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39875033|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39875033|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39970215|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39970215|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39544072|Female|Other mesenchymal|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39544072|Female|Other mesenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|312|38177564|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|299|38305772|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|293|38466303|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|191951502|Female|Pilocytic astrocytoma|2006-2010|~|~|~
0-19|0.8|0.8|0.8|Malignant|1543|191951502|Female|Pilocytic astrocytoma|2006-2010|0.8|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|320|39682297|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|310|39875033|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.9|0.8|Malignant|317|39970215|Female|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|345|39544072|Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|38177564|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|38305772|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|38305772|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38466303|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|38466303|Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|191951502|Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|65|191951502|Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|39682297|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|39682297|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|39875033|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|39875033|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39970215|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|39970215|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Pineal parenchymal|2010|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|227|38177564|Female|Pituitary|2004|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|38177564|Female|Pituitary|2004|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|259|38305772|Female|Pituitary|2005|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|38305772|Female|Pituitary|2005|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|287|38466303|Female|Pituitary|2006|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|38466303|Female|Pituitary|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|1479|191951502|Female|Pituitary|2006-2010|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|191951502|Female|Pituitary|2006-2010|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|288|39682297|Female|Pituitary|2007|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39682297|Female|Pituitary|2007|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|311|39875033|Female|Pituitary|2008|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39875033|Female|Pituitary|2008|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|293|39970215|Female|Pituitary|2009|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|39970215|Female|Pituitary|2009|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|330|39544072|Female|Pituitary|2010|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39544072|Female|Pituitary|2010|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|688|38177564|Female|Total|2004|1.7|1.9|1.8
0-19|3.1|3.5|3.3|Malignant|1249|38177564|Female|Total|2004|3.1|3.5|3.3
0-19|2.0|2.3|2.1|Benign/Borderline|829|38305772|Female|Total|2005|2.0|2.3|2.2
0-19|2.9|3.2|3.0|Malignant|1158|38305772|Female|Total|2005|2.9|3.2|3.0
0-19|2.0|2.3|2.1|Benign/Borderline|829|38466303|Female|Total|2006|2.0|2.3|2.2
0-19|2.8|3.2|3.0|Malignant|1154|38466303|Female|Total|2006|2.8|3.2|3.0
0-19|2.1|2.3|2.2|Benign/Borderline|4282|191951502|Female|Total|2006-2010|2.2|2.3|2.2
0-19|3.0|3.1|3.1|Malignant|5859|191951502|Female|Total|2006-2010|3.0|3.1|3.1
0-19|2.0|2.3|2.1|Benign/Borderline|863|39682297|Female|Total|2007|2.0|2.3|2.2
0-19|3.0|3.4|3.2|Malignant|1257|39682297|Female|Total|2007|3.0|3.3|3.2
0-19|2.1|2.4|2.2|Benign/Borderline|901|39875033|Female|Total|2008|2.1|2.4|2.3
0-19|2.9|3.2|3.1|Malignant|1219|39875033|Female|Total|2008|2.9|3.2|3.1
0-19|2.0|2.3|2.2|Benign/Borderline|889|39970215|Female|Total|2009|2.1|2.4|2.2
0-19|2.9|3.2|3.0|Malignant|1211|39970215|Female|Total|2009|2.9|3.2|3.0
0-19|2.1|2.4|2.3|Benign/Borderline|911|39544072|Female|Total|2010|2.2|2.5|2.3
0-19|2.8|3.2|3.0|Malignant|1184|39544072|Female|Total|2010|2.8|3.2|3.0
0-19|0.2|0.3|0.2|Benign/Borderline|91|38177564|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38177564|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|139|38305772|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|38305772|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|38466303|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|38466303|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|527|191951502|Female|Tumors of Cranial and Spinal Nerves|2006-2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|191951502|Female|Tumors of Cranial and Spinal Nerves|2006-2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|39682297|Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39682297|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|117|39875033|Female|Tumors of Cranial and Spinal Nerves|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|39875033|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|39970215|Female|Tumors of Cranial and Spinal Nerves|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39970215|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|39544072|Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39544072|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|173|38177564|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1155|38177564|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.5|0.5|Benign/Borderline|178|38305772|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
0-19|2.6|3.0|2.8|Malignant|1071|38305772|Female|Tumors of Neuroepthelial Tissue|2005|2.6|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|189|38466303|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.0|2.8|Malignant|1090|38466303|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.8
0-19|0.5|0.5|0.5|Benign/Borderline|980|191951502|Female|Tumors of Neuroepthelial Tissue|2006-2010|0.5|0.5|0.5
0-19|2.8|3.0|2.9|Malignant|5531|191951502|Female|Tumors of Neuroepthelial Tissue|2006-2010|2.8|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|215|39682297|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1195|39682297|Female|Tumors of Neuroepthelial Tissue|2007|2.8|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|39875033|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.8|3.1|2.9|Malignant|1166|39875033|Female|Tumors of Neuroepthelial Tissue|2008|2.8|3.1|2.9
0-19|0.4|0.5|0.5|Benign/Borderline|186|39970215|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
0-19|2.7|3.0|2.8|Malignant|1128|39970215|Female|Tumors of Neuroepthelial Tissue|2009|2.7|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|205|39544072|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.6|0.5
0-19|2.6|3.0|2.8|Malignant|1108|39544072|Female|Tumors of Neuroepthelial Tissue|2010|2.6|3.0|2.8
0-19|0.7|0.9|0.8|Benign/Borderline|304|38177564|Female|Tumors of Sellar Region|2004|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|38177564|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|332|38305772|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|38305772|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|360|38466303|Female|Tumors of Sellar Region|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|38466303|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|1861|191951502|Female|Tumors of Sellar Region|2006-2010|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|191951502|Female|Tumors of Sellar Region|2006-2010|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|377|39682297|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39682297|Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|371|39875033|Female|Tumors of Sellar Region|2008|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39875033|Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|380|39970215|Female|Tumors of Sellar Region|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39970215|Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|414|39544072|Female|Tumors of Sellar Region|2010|0.9|1.2|1.0
0-19|~|~|~|Malignant|~|39544072|Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|38177564|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38177564|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|38305772|Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38305772|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|38466303|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38466303|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|394|191951502|Female|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|45|191951502|Female|Tumors of the Meninges|2006-2010|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|86|39682297|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39682297|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|39875033|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39875033|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|39970215|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39970215|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|39544072|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39544072|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|38177564|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|38177564|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|72|38305772|Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|19|38305772|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|38466303|Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|38466303|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|441|191951502|Female|Unclassified Tumors|2006-2010|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|87|191951502|Female|Unclassified Tumors|2006-2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|39682297|Female|Unclassified Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|39682297|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|106|39875033|Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|16|39875033|Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|99|39970215|Female|Unclassified Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|20|39970215|Female|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|108|39544072|Female|Unclassified Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39544072|Female|Unclassified Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|38177564|Female|Unique astrocytoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|38177564|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|18|38305772|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|38305772|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|22|38466303|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38466303|Female|Unique astrocytoma variants|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|105|191951502|Female|Unique astrocytoma variants|2006-2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|82|191951502|Female|Unique astrocytoma variants|2006-2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|39682297|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|32|39682297|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|39875033|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39875033|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39970215|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|39970215|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39544072|Female|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|39544072|Female|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|All other|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|201277501|Male|All other|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|40123936|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40236151|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40380809|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Anaplastic astrocytoma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|199|201277501|Male|Anaplastic astrocytoma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|41633209|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|41|41808227|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|41876403|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|41|41417074|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Anaplastic oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|201277501|Male|Anaplastic oligodendroglioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|40123936|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40236151|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40380809|Male|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Astrocytoma, NOS|2006-2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|479|201277501|Male|Astrocytoma, NOS|2006-2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|41633209|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|41808227|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|41876403|Male|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|41417074|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|40123936|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|40236151|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40236151|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|40380809|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40380809|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|164|201277501|Male|Choroid plexus|2006-2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|52|201277501|Male|Choroid plexus|2006-2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|31|41633209|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41633209|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41808227|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41808227|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41876403|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41876403|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41417074|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41417074|Male|Choroid plexus|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40123936|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40123936|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|40236151|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40236151|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40380809|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40380809|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|380|201277501|Male|Craniopharyngioma|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|201277501|Male|Craniopharyngioma|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|41633209|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41633209|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|41808227|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41808227|Male|Craniopharyngioma|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|41876403|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41876403|Male|Craniopharyngioma|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|41417074|Male|Craniopharyngioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41417074|Male|Craniopharyngioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40123936|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40236151|Male|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40380809|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Diffuse astrocytoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|88|201277501|Male|Diffuse astrocytoma|2006-2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41633209|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|41808227|Male|Diffuse astrocytoma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|41876403|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|276|40123936|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|267|40236151|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|287|40380809|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|1445|201277501|Male|Embryonal/primitive/medulloblastoma|2006-2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|41633209|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|313|41808227|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|41876403|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|301|41417074|Male|Embryonal/primitive/medulloblastoma|2010|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40236151|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40236151|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40380809|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40380809|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|104|201277501|Male|Ependymoma variants|2006-2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|201277501|Male|Ependymoma variants|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41633209|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41633209|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41876403|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41876403|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|41417074|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41417074|Male|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40123936|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|40236151|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|40380809|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Ependymoma/anaplastic ependymoma|2006-2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|516|201277501|Male|Ependymoma/anaplastic ependymoma|2006-2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|41633209|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41808227|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41876403|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|41417074|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|16|40123936|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|98|40123936|Male|Germ Cell Tumors|2004|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|40236151|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|84|40236151|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|24|40380809|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|96|40380809|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|97|201277501|Male|Germ Cell Tumors|2006-2010|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|489|201277501|Male|Germ Cell Tumors|2006-2010|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|41633209|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|96|41633209|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|41808227|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|115|41808227|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|23|41876403|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|91|41876403|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|41417074|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|103|41417074|Male|Germ Cell Tumors|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40123936|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|40236151|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|64|40380809|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Glioblastoma|2006-2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|330|201277501|Male|Glioblastoma|2006-2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|41633209|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.1|Malignant|62|41808227|Male|Glioblastoma|2008|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|41876403|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|63|41417074|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|225|40123936|Male|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|40236151|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|231|40380809|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|29|201277501|Male|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
0-19|0.6|0.6|0.6|Malignant|1171|201277501|Male|Glioma malignant, NOS|2006-2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|238|41633209|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|251|41808227|Male|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.5|0.7|0.6|Malignant|253|41876403|Male|Glioma malignant, NOS|2009|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|41417074|Male|Glioma malignant, NOS|2010|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|40123936|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40123936|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|64|201277501|Male|Hemangioblastoma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|201277501|Male|Hemangioblastoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41633209|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41633209|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40123936|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40236151|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40236151|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40380809|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40380809|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|193|201277501|Male|Hemangioma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|201277501|Male|Hemangioma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|41633209|Male|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41633209|Male|Hemangioma|2007|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41808227|Male|Hemangioma|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41808227|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|41876403|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41876403|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|41417074|Male|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41417074|Male|Hemangioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Local Extensions from Regional Tumors|2006-2010|~|~|~
0-19|~|~|~|Malignant|~|201277501|Male|Local Extensions from Regional Tumors|2006-2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|47|201277501|Male|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40123936|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40236151|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40236151|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|40380809|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40380809|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|245|201277501|Male|Meningioma|2006-2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|19|201277501|Male|Meningioma|2006-2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|48|41633209|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41633209|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|41808227|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41808227|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|41876403|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41876403|Male|Meningioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41417074|Male|Meningioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41417074|Male|Meningioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Mixed glioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|67|201277501|Male|Mixed glioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Mixed glioma|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Mixed glioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41417074|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|27|40123936|Male|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Neoplasm, unspecified|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40236151|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|40236151|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|46|40380809|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|25|40380809|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|283|201277501|Male|Neoplasm, unspecified|2006-2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|104|201277501|Male|Neoplasm, unspecified|2006-2010|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|61|41633209|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|22|41633209|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|42|41808227|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|41808227|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|83|41876403|Male|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|41876403|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|63|41417074|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|41417074|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|111|40123936|Male|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40123936|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|40236151|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40236151|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40380809|Male|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40380809|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|576|201277501|Male|Nerve sheath, benign and malignant|2006-2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201277501|Male|Nerve sheath, benign and malignant|2006-2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|41633209|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41633209|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|120|41808227|Male|Nerve sheath, benign and malignant|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41808227|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|41876403|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41876403|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41417074|Male|Nerve sheath, benign and malignant|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41417074|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Neuroepithelial|2006-2010|~|~|~
0-19|~|~|~|Malignant|~|201277501|Male|Neuroepithelial|2006-2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Neuroepithelial|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|142|40123936|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|40123936|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|149|40236151|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|40236151|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|146|40380809|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|30|40380809|Male|Neuronal/glial, neuronal|2006|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|751|201277501|Male|Neuronal/glial, neuronal|2006-2010|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|112|201277501|Male|Neuronal/glial, neuronal|2006-2010|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|161|41633209|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|41633209|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|41808227|Male|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|27|41808227|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|149|41876403|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41876403|Male|Neuronal/glial, neuronal|2009|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|153|41417074|Male|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41417074|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|40123936|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|40236151|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40380809|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|115|201277501|Male|Oligodendroglioma|2006-2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|41633209|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|30|41808227|Male|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41876403|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41417074|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|40123936|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40236151|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40236151|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40380809|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40380809|Male|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|75|201277501|Male|Other mesenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|22|201277501|Male|Other mesenchymal|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|41633209|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Other mesenchymal|2008|~|~|~
0-19|~|~|~|Malignant|~|41808227|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41876403|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41876403|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41417074|Male|Other mesenchymal|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41417074|Male|Other mesenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|350|40123936|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|321|40236151|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|338|40380809|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Pilocytic astrocytoma|2006-2010|~|~|~
0-19|0.8|0.9|0.8|Malignant|1667|201277501|Male|Pilocytic astrocytoma|2006-2010|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|333|41633209|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|367|41808227|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.9|0.8|Malignant|344|41876403|Male|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.7|0.9|0.8|Malignant|343|41417074|Male|Pilocytic astrocytoma|2010|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40123936|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40123936|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40236151|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|40236151|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40380809|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40380809|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|201277501|Male|Pineal parenchymal|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|68|201277501|Male|Pineal parenchymal|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41633209|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41633209|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41808227|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|41808227|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41876403|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|41876403|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41417074|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|41417074|Male|Pineal parenchymal|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|40123936|Male|Pituitary|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40123936|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|40236151|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40236151|Male|Pituitary|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|40380809|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40380809|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|543|201277501|Male|Pituitary|2006-2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|201277501|Male|Pituitary|2006-2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|41633209|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41633209|Male|Pituitary|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|120|41808227|Male|Pituitary|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41808227|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|41876403|Male|Pituitary|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41876403|Male|Pituitary|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41417074|Male|Pituitary|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41417074|Male|Pituitary|2010|~|~|~
0-19|1.4|1.7|1.5|Benign/Borderline|619|40123936|Male|Total|2004|1.4|1.7|1.5
0-19|3.4|3.8|3.6|Malignant|1427|40123936|Male|Total|2004|3.4|3.7|3.6
0-19|1.6|1.9|1.7|Benign/Borderline|705|40236151|Male|Total|2005|1.6|1.9|1.8
0-19|3.2|3.5|3.4|Malignant|1345|40236151|Male|Total|2005|3.2|3.5|3.3
0-19|1.6|1.9|1.8|Benign/Borderline|720|40380809|Male|Total|2006|1.7|1.9|1.8
0-19|3.4|3.8|3.6|Malignant|1442|40380809|Male|Total|2006|3.4|3.8|3.6
0-19|1.7|1.9|1.8|Benign/Borderline|3655|201277501|Male|Total|2006-2010|1.8|1.9|1.8
0-19|3.5|3.7|3.6|Malignant|7160|201277501|Male|Total|2006-2010|3.5|3.6|3.6
0-19|1.7|1.9|1.8|Benign/Borderline|758|41633209|Male|Total|2007|1.7|2.0|1.8
0-19|3.4|3.7|3.5|Malignant|1469|41633209|Male|Total|2007|3.4|3.7|3.5
0-19|1.6|1.9|1.8|Benign/Borderline|743|41808227|Male|Total|2008|1.7|1.9|1.8
0-19|3.5|3.9|3.7|Malignant|1532|41808227|Male|Total|2008|3.5|3.9|3.7
0-19|1.8|2.1|2.0|Benign/Borderline|827|41876403|Male|Total|2009|1.8|2.1|2.0
0-19|3.4|3.7|3.5|Malignant|1479|41876403|Male|Total|2009|3.4|3.7|3.5
0-19|1.6|1.9|1.7|Benign/Borderline|722|41417074|Male|Total|2010|1.6|1.9|1.7
0-19|3.3|3.7|3.5|Malignant|1454|41417074|Male|Total|2010|3.3|3.7|3.5
0-19|0.2|0.3|0.3|Benign/Borderline|111|40123936|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40123936|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|40236151|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40236151|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40380809|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40380809|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|576|201277501|Male|Tumors of Cranial and Spinal Nerves|2006-2010|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201277501|Male|Tumors of Cranial and Spinal Nerves|2006-2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|41633209|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41633209|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|120|41808227|Male|Tumors of Cranial and Spinal Nerves|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41808227|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|41876403|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41876403|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41417074|Male|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41417074|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|213|40123936|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.3|Malignant|1296|40123936|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|241|40236151|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1215|40236151|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|239|40380809|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1299|40380809|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.6|0.6|0.6|Benign/Borderline|1197|201277501|Male|Tumors of Neuroepthelial Tissue|2006-2010|0.6|0.6|0.6
0-19|3.1|3.3|3.2|Malignant|6441|201277501|Male|Tumors of Neuroepthelial Tissue|2006-2010|3.1|3.3|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|248|41633209|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1325|41633209|Male|Tumors of Neuroepthelial Tissue|2007|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|247|41808227|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1370|41808227|Male|Tumors of Neuroepthelial Tissue|2008|3.1|3.5|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|247|41876403|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1340|41876403|Male|Tumors of Neuroepthelial Tissue|2009|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|241|41417074|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|1306|41417074|Male|Tumors of Neuroepthelial Tissue|2010|3.0|3.3|3.2
0-19|0.3|0.5|0.4|Benign/Borderline|156|40123936|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40123936|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|192|40236151|Male|Tumors of Sellar Region|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|40236151|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40380809|Male|Tumors of Sellar Region|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40380809|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|923|201277501|Male|Tumors of Sellar Region|2006-2010|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|201277501|Male|Tumors of Sellar Region|2006-2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|190|41633209|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41633209|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|209|41808227|Male|Tumors of Sellar Region|2008|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|41808227|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|213|41876403|Male|Tumors of Sellar Region|2009|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|41876403|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|176|41417074|Male|Tumors of Sellar Region|2010|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41417074|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40123936|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40123936|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40236151|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40236151|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|40380809|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40380809|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|384|201277501|Male|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|41|201277501|Male|Tumors of the Meninges|2006-2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|75|41633209|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41633209|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|41808227|Male|Tumors of the Meninges|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41808227|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|41876403|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41876403|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41417074|Male|Tumors of the Meninges|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41417074|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40123936|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Unclassified Tumors|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40236151|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|40236151|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|40380809|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|40380809|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|477|201277501|Male|Unclassified Tumors|2006-2010|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|111|201277501|Male|Unclassified Tumors|2006-2010|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|101|41633209|Male|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|26|41633209|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|72|41808227|Male|Unclassified Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|41808227|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|41876403|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|41876403|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|108|41417074|Male|Unclassified Tumors|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|41417074|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|40123936|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40123936|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40236151|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40236151|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40380809|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40380809|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|132|201277501|Male|Unique astrocytoma variants|2006-2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|96|201277501|Male|Unique astrocytoma variants|2006-2010|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|41633209|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|21|41633209|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41808227|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41808227|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|41876403|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|41876403|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|41417074|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41417074|Male|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|78301500|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|78541923|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|78847112|Male and Female|All other|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|393229003|Male and Female|All other|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|29|393229003|Male and Female|All other|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|81315506|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|81683260|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|81846618|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|80961146|Male and Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|78301500|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|58|78541923|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|63|78847112|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Anaplastic astrocytoma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|353|393229003|Male and Female|Anaplastic astrocytoma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|82|81315506|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|72|81683260|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|81846618|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|77|80961146|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|78301500|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|78541923|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|78847112|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Anaplastic oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|43|393229003|Male and Female|Anaplastic oligodendroglioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|81315506|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|81683260|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|81846618|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|80961146|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|78301500|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|78541923|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|78847112|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Astrocytoma, NOS|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Malignant|890|393229003|Male and Female|Astrocytoma, NOS|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|177|81315506|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|177|81683260|Male and Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|188|81846618|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|80961146|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|53|78301500|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|78301500|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|51|78541923|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|78541923|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|78847112|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|19|78847112|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|310|393229003|Male and Female|Choroid plexus|2006-2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|89|393229003|Male and Female|Choroid plexus|2006-2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|81315506|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81315506|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|72|81683260|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|81683260|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|81846618|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81846618|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|80961146|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|80961146|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|156|78301500|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|78301500|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|78541923|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|78541923|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|148|78847112|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|78847112|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|762|393229003|Male and Female|Craniopharyngioma|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|393229003|Male and Female|Craniopharyngioma|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|170|81315506|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81315506|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|149|81683260|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81683260|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|160|81846618|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81846618|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|80961146|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|80961146|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|41|78301500|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|39|78541923|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|29|78847112|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Diffuse astrocytoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|171|393229003|Male and Female|Diffuse astrocytoma|2006-2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|40|81315506|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|81683260|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|81846618|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|29|80961146|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|484|78301500|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|438|78541923|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|483|78847112|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
0-19|0.6|0.6|0.6|Malignant|2431|393229003|Male and Female|Embryonal/primitive/medulloblastoma|2006-2010|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|511|81315506|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|542|81683260|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|498|81846618|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|475|80961146|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|23|78301500|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78301500|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|78541923|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78541923|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|78847112|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78847112|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|159|393229003|Male and Female|Ependymoma variants|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|393229003|Male and Female|Ependymoma variants|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|29|81315506|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81315506|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|81683260|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81683260|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|81846618|Male and Female|Ependymoma variants|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81846618|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|80961146|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|80961146|Male and Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|189|78301500|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|198|78541923|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|198|78847112|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Ependymoma/anaplastic ependymoma|2006-2010|~|~|~
0-19|0.2|0.2|0.2|Malignant|900|393229003|Male and Female|Ependymoma/anaplastic ependymoma|2006-2010|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|176|81315506|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|81683260|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|187|81846618|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|80961146|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|29|78301500|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|78301500|Male and Female|Germ Cell Tumors|2004|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|78541923|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|127|78541923|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|78847112|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|119|78847112|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|175|393229003|Male and Female|Germ Cell Tumors|2006-2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|656|393229003|Male and Female|Germ Cell Tumors|2006-2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|81315506|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|129|81315506|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|81683260|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|141|81683260|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|81846618|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|133|81846618|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|80961146|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|150|80961146|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|123|78301500|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|94|78541923|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|105|78847112|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Glioblastoma|2006-2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|572|393229003|Male and Female|Glioblastoma|2006-2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81315506|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|123|81683260|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|118|81846618|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|114|80961146|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|450|78301500|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|437|78541923|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|465|78847112|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|58|393229003|Male and Female|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
0-19|0.6|0.6|0.6|Malignant|2377|393229003|Male and Female|Glioma malignant, NOS|2006-2010|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|491|81315506|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|504|81683260|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|531|81846618|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|19|80961146|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.5|0.6|0.6|Malignant|446|80961146|Male and Female|Glioma malignant, NOS|2010|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|28|78301500|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78301500|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|78541923|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78541923|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|78847112|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78847112|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|114|393229003|Male and Female|Hemangioblastoma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|393229003|Male and Female|Hemangioblastoma|2006-2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|81315506|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81315506|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|19|81683260|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81683260|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|81846618|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81846618|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|19|80961146|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|80961146|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|78301500|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78301500|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|78541923|Male and Female|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78541923|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|55|78847112|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|78847112|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|353|393229003|Male and Female|Hemangioma|2006-2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|393229003|Male and Female|Hemangioma|2006-2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81315506|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81315506|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|81683260|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81683260|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|92|81846618|Male and Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81846618|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|79|80961146|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|80961146|Male and Female|Hemangioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|78301500|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|78541923|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|78847112|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Local Extensions from Regional Tumors|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|393229003|Male and Female|Local Extensions from Regional Tumors|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|81315506|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|81683260|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|81846618|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|80961146|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|78301500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|78541923|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|78847112|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|66|393229003|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|81315506|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|81683260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81846618|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|80961146|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|82|78301500|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|78301500|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|78541923|Male and Female|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|78541923|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|86|78847112|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|78847112|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|505|393229003|Male and Female|Meningioma|2006-2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|29|393229003|Male and Female|Meningioma|2006-2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|101|81315506|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81315506|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|81683260|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81683260|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|81846618|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81846618|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|101|80961146|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|80961146|Male and Female|Meningioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|78301500|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|29|78541923|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|78847112|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Mixed glioma|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|140|393229003|Male and Female|Mixed glioma|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81315506|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81683260|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|81846618|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|80961146|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|58|78301500|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|40|78301500|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|101|78541923|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|36|78541923|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|92|78847112|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|48|78847112|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|564|393229003|Male and Female|Neoplasm, unspecified|2006-2010|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|186|393229003|Male and Female|Neoplasm, unspecified|2006-2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|105|81315506|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|81315506|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|110|81683260|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|36|81683260|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|140|81846618|Male and Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|42|81846618|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|136|80961146|Male and Female|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|28|80961146|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|202|78301500|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|78301500|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|244|78541923|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|78541923|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|78847112|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|78847112|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1103|393229003|Male and Female|Nerve sheath, benign and malignant|2006-2010|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|17|393229003|Male and Female|Nerve sheath, benign and malignant|2006-2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|231|81315506|Male and Female|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81315506|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|237|81683260|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81683260|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|242|81846618|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81846618|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|193|80961146|Male and Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|80961146|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|78301500|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|78541923|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|78847112|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Neuroepithelial|2006-2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|39|393229003|Male and Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|81315506|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|81683260|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|81846618|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|80961146|Male and Female|Neuroepithelial|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|252|78301500|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|49|78301500|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|277|78541923|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|52|78541923|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|260|78847112|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|53|78847112|Male and Female|Neuronal/glial, neuronal|2006|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|1363|393229003|Male and Female|Neuronal/glial, neuronal|2006-2010|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|224|393229003|Male and Female|Neuronal/glial, neuronal|2006-2010|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|291|81315506|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|60|81315506|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|285|81683260|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|81683260|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|274|81846618|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|81846618|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|289|80961146|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|36|80961146|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|59|78301500|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|78541923|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|78847112|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Oligodendroglioma|2006-2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|217|393229003|Male and Female|Oligodendroglioma|2006-2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|81315506|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|81683260|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|81846618|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|41|80961146|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|26|78301500|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78301500|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|78541923|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78541923|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|78847112|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78847112|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|159|393229003|Male and Female|Other mesenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|56|393229003|Male and Female|Other mesenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|25|81315506|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81315506|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|31|81683260|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81683260|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81846618|Male and Female|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81846618|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|80961146|Male and Female|Other mesenchymal|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|80961146|Male and Female|Other mesenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|662|78301500|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|620|78541923|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|631|78847112|Male and Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|393229003|Male and Female|Pilocytic astrocytoma|2006-2010|~|~|~
0-19|0.8|0.8|0.8|Malignant|3210|393229003|Male and Female|Pilocytic astrocytoma|2006-2010|0.8|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|653|81315506|Male and Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|81683260|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|661|81846618|Male and Female|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|0.9|0.9|Malignant|688|80961146|Male and Female|Pilocytic astrocytoma|2010|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|78301500|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|29|78301500|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78541923|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|78541923|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|78847112|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|78847112|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|35|393229003|Male and Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|133|393229003|Male and Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81315506|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|81315506|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81683260|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|81683260|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81846618|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|81846618|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|80961146|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|80961146|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|304|78301500|Male and Female|Pituitary|2004|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|78301500|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|368|78541923|Male and Female|Pituitary|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|78541923|Male and Female|Pituitary|2005|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|371|78847112|Male and Female|Pituitary|2006|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|78847112|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|2022|393229003|Male and Female|Pituitary|2006-2010|0.5|0.5|0.5
0-19|~|~|~|Malignant|~|393229003|Male and Female|Pituitary|2006-2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|397|81315506|Male and Female|Pituitary|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|81315506|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|431|81683260|Male and Female|Pituitary|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|81683260|Male and Female|Pituitary|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|433|81846618|Male and Female|Pituitary|2009|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|81846618|Male and Female|Pituitary|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|433|80961146|Male and Female|Pituitary|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|80961146|Male and Female|Pituitary|2010|~|~|~
0-19|1.6|1.8|1.7|Benign/Borderline|1307|78301500|Male and Female|Total|2004|1.6|1.8|1.7
0-19|3.3|3.6|3.4|Malignant|2676|78301500|Male and Female|Total|2004|3.3|3.5|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|1534|78541923|Male and Female|Total|2005|1.9|2.1|2.0
0-19|3.1|3.3|3.2|Malignant|2503|78541923|Male and Female|Total|2005|3.1|3.3|3.2
0-19|1.8|2.0|1.9|Benign/Borderline|1549|78847112|Male and Female|Total|2006|1.9|2.1|2.0
0-19|3.2|3.4|3.3|Malignant|2596|78847112|Male and Female|Total|2006|3.2|3.4|3.3
0-19|1.9|2.0|2.0|Benign/Borderline|7937|393229003|Male and Female|Total|2006-2010|2.0|2.1|2.0
0-19|3.3|3.4|3.3|Malignant|13019|393229003|Male and Female|Total|2006-2010|3.3|3.4|3.3
0-19|1.9|2.1|2.0|Benign/Borderline|1621|81315506|Male and Female|Total|2007|1.9|2.1|2.0
0-19|3.2|3.5|3.4|Malignant|2726|81315506|Male and Female|Total|2007|3.2|3.5|3.4
0-19|1.9|2.1|2.0|Benign/Borderline|1644|81683260|Male and Female|Total|2008|1.9|2.1|2.0
0-19|3.3|3.5|3.4|Malignant|2751|81683260|Male and Female|Total|2008|3.2|3.5|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1716|81846618|Male and Female|Total|2009|2.0|2.2|2.1
0-19|3.2|3.4|3.3|Malignant|2690|81846618|Male and Female|Total|2009|3.2|3.4|3.3
0-19|1.9|2.1|2.0|Benign/Borderline|1633|80961146|Male and Female|Total|2010|1.9|2.1|2.0
0-19|3.1|3.4|3.3|Malignant|2638|80961146|Male and Female|Total|2010|3.1|3.4|3.3
0-19|0.2|0.3|0.3|Benign/Borderline|202|78301500|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|78301500|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|244|78541923|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|78541923|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|78847112|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|78847112|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1103|393229003|Male and Female|Tumors of Cranial and Spinal Nerves|2006-2010|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|17|393229003|Male and Female|Tumors of Cranial and Spinal Nerves|2006-2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|231|81315506|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81315506|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|237|81683260|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81683260|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|242|81846618|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81846618|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|193|80961146|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|80961146|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|386|78301500|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|3.0|3.3|3.1|Malignant|2451|78301500|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|419|78541923|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.8|3.0|2.9|Malignant|2286|78541923|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|428|78847112|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|2389|78847112|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|2177|393229003|Male and Female|Tumors of Neuroepthelial Tissue|2006-2010|0.5|0.6|0.6
0-19|3.0|3.1|3.1|Malignant|11972|393229003|Male and Female|Tumors of Neuroepthelial Tissue|2006-2010|3.0|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|463|81315506|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2520|81315506|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|454|81683260|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2536|81683260|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.0|3.2|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|433|81846618|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|2468|81846618|Male and Female|Tumors of Neuroepthelial Tissue|2009|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|446|80961146|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2414|80961146|Male and Female|Tumors of Neuroepthelial Tissue|2010|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|460|78301500|Male and Female|Tumors of Sellar Region|2004|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|78301500|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|524|78541923|Male and Female|Tumors of Sellar Region|2005|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|78541923|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|519|78847112|Male and Female|Tumors of Sellar Region|2006|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|78847112|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.7|0.7|Benign/Borderline|2784|393229003|Male and Female|Tumors of Sellar Region|2006-2010|0.7|0.7|0.7
0-19|~|~|~|Malignant|~|393229003|Male and Female|Tumors of Sellar Region|2006-2010|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|567|81315506|Male and Female|Tumors of Sellar Region|2007|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|81315506|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|580|81683260|Male and Female|Tumors of Sellar Region|2008|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|81683260|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|593|81846618|Male and Female|Tumors of Sellar Region|2009|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|81846618|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|590|80961146|Male and Female|Tumors of Sellar Region|2010|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|80961146|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|136|78301500|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|78301500|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|173|78541923|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|78541923|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|140|78847112|Male and Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|78847112|Male and Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|778|393229003|Male and Female|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|86|393229003|Male and Female|Tumors of the Meninges|2006-2010|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|161|81315506|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|81315506|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|158|81683260|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81683260|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|173|81846618|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|23|81846618|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|156|80961146|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|80961146|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|93|78301500|Male and Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|40|78301500|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|140|78541923|Male and Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|78541923|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|147|78847112|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|49|78847112|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|918|393229003|Male and Female|Unclassified Tumors|2006-2010|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|198|393229003|Male and Female|Unclassified Tumors|2006-2010|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|168|81315506|Male and Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|43|81315506|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|178|81683260|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|38|81683260|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|232|81846618|Male and Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|44|81846618|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|216|80961146|Male and Female|Unclassified Tumors|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|31|80961146|Male and Female|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|40|78301500|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|78301500|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|49|78541923|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|28|78541923|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|45|78847112|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|34|78847112|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|237|393229003|Male and Female|Unique astrocytoma variants|2006-2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|178|393229003|Male and Female|Unique astrocytoma variants|2006-2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|81315506|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|53|81315506|Male and Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|50|81683260|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|81683260|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|57|81846618|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|41|81846618|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|32|80961146|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|24|80961146|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104421375|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|104421375|Female|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|105570557|Female|All other|2005|~|~|~
20+|~|~|~|Malignant|~|105570557|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106756918|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106756918|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|79|540263219|Female|All other|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|540263219|Female|All other|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110861505|Female|All other|2007|~|~|~
20+|~|~|~|Malignant|~|110861505|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|112086310|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|112086310|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|113333902|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113333902|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|113527847|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113527847|Female|All other|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|544|104421375|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|105570557|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|488|105570557|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|106756918|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|487|106756918|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|540263219|Female|Anaplastic astrocytoma|2006-2010|~|~|~
20+|0.4|0.5|0.4|Malignant|2460|540263219|Female|Anaplastic astrocytoma|2006-2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|110861505|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|520|110861505|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112086310|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|489|112086310|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113333902|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|484|113333902|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113527847|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|529|113527847|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|104421375|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|176|104421375|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105570557|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|156|105570557|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106756918|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|129|106756918|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|540263219|Female|Anaplastic oligodendroglioma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|675|540263219|Female|Anaplastic oligodendroglioma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110861505|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|149|110861505|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112086310|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|161|112086310|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113333902|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|141|113333902|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113527847|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|120|113527847|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104421375|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|548|104421375|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|105570557|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|527|105570557|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|106756918|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|506|106756918|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|540263219|Female|Astrocytoma, NOS|2006-2010|~|~|~
20+|0.4|0.4|0.4|Malignant|2327|540263219|Female|Astrocytoma, NOS|2006-2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110861505|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|517|110861505|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112086310|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|474|112086310|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113333902|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|470|113333902|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113527847|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|446|113527847|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|36|104421375|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104421375|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|105570557|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105570557|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|39|106756918|Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106756918|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|222|540263219|Female|Choroid plexus|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|540263219|Female|Choroid plexus|2006-2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|110861505|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|110861505|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|112086310|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112086310|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|44|113333902|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|113333902|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|113527847|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|113527847|Female|Choroid plexus|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|104421375|Female|Craniopharyngioma|2004|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104421375|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|177|105570557|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|105570557|Female|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|106756918|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106756918|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1008|540263219|Female|Craniopharyngioma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|540263219|Female|Craniopharyngioma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|210|110861505|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110861505|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|210|112086310|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112086310|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|113333902|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113333902|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|113527847|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113527847|Female|Craniopharyngioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|105|104421375|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105570557|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|120|105570557|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106756918|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|81|106756918|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|540263219|Female|Diffuse astrocytoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|582|540263219|Female|Diffuse astrocytoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110861505|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|113|110861505|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112086310|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|117|112086310|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113333902|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|138|113333902|Female|Diffuse astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113527847|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|146|113527847|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104421375|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|67|104421375|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105570557|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|81|105570557|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106756918|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|69|106756918|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|540263219|Female|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|402|540263219|Female|Embryonal/primitive/medulloblastoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110861505|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|88|110861505|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112086310|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|85|112086310|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113333902|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|101|113333902|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113527847|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.0|0.1|0.1|Malignant|69|113527847|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|101|104421375|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|104421375|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|115|105570557|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|105570557|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|135|106756918|Female|Ependymoma variants|2006|0.1|0.1|0.1
20+|~|~|~|Malignant|~|106756918|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|549|540263219|Female|Ependymoma variants|2006-2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|540263219|Female|Ependymoma variants|2006-2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|108|110861505|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110861505|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|106|112086310|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112086310|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|105|113333902|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|113333902|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|110|113527847|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|113527847|Female|Ependymoma variants|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|270|104421375|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105570557|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|288|105570557|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106756918|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|278|106756918|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|28|540263219|Female|Ependymoma/anaplastic ependymoma|2006-2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1426|540263219|Female|Ependymoma/anaplastic ependymoma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110861505|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|284|110861505|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112086310|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|305|112086310|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113333902|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|327|113333902|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113527847|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|276|113527847|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|104421375|Female|Germ Cell Tumors|2004|~|~|~
20+|~|~|~|Malignant|~|104421375|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|105570557|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105570557|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|106756918|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106756918|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|151|540263219|Female|Germ Cell Tumors|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|540263219|Female|Germ Cell Tumors|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|110861505|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110861505|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|112086310|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112086310|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|113333902|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113333902|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|113527847|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113527847|Female|Germ Cell Tumors|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|3913|104421375|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|105570557|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4000|105570557|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|106756918|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.7|3.6|Malignant|4110|106756918|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|540263219|Female|Glioblastoma|2006-2010|~|~|~
20+|3.5|3.6|3.5|Malignant|20899|540263219|Female|Glioblastoma|2006-2010|3.8|3.9|3.9
20+|~|~|~|Benign/Borderline|~|110861505|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4300|110861505|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|112086310|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4325|112086310|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|113333902|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4365|113333902|Female|Glioblastoma|2009|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|113527847|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4397|113527847|Female|Glioblastoma|2010|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|104421375|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|399|104421375|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|105570557|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|373|105570557|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106756918|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|381|106756918|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|540263219|Female|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|1988|540263219|Female|Glioma malignant, NOS|2006-2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110861505|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|404|110861505|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112086310|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|422|112086310|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|113333902|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|487|113333902|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113527847|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|370|113527847|Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|193|104421375|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104421375|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|213|105570557|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105570557|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|204|106756918|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106756918|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1032|540263219|Female|Hemangioblastoma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|540263219|Female|Hemangioblastoma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|203|110861505|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110861505|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|112086310|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112086310|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|113333902|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113333902|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|207|113527847|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113527847|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|213|104421375|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104421375|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|252|105570557|Female|Hemangioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105570557|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|281|106756918|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106756918|Female|Hemangioma|2006|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2012|540263219|Female|Hemangioma|2006-2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|540263219|Female|Hemangioma|2006-2010|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|336|110861505|Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|110861505|Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|413|112086310|Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|112086310|Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|452|113333902|Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|113333902|Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|561|113527847|Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|113527847|Female|Hemangioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|104421375|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105570557|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|20|105570557|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106756918|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|17|106756918|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|540263219|Female|Local Extensions from Regional Tumors|2006-2010|~|~|~
20+|0.0|0.0|0.0|Malignant|106|540263219|Female|Local Extensions from Regional Tumors|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110861505|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|110861505|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112086310|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112086310|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113333902|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|113333902|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113527847|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|21|113527847|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104421375|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|570|104421375|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|105570557|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|642|105570557|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106756918|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|648|106756918|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|540263219|Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
20+|0.5|0.6|0.6|Malignant|3224|540263219|Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110861505|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|615|110861505|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|112086310|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|682|112086310|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|113333902|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|641|113333902|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|113527847|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|716|113527847|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|11.5|11.9|11.7|Benign/Borderline|13035|104421375|Female|Meningioma|2004|12.3|12.7|12.5
20+|0.2|0.3|0.2|Malignant|271|104421375|Female|Meningioma|2004|0.2|0.3|0.3
20+|12.9|13.3|13.1|Benign/Borderline|14837|105570557|Female|Meningioma|2005|13.8|14.3|14.1
20+|0.2|0.3|0.2|Malignant|272|105570557|Female|Meningioma|2005|0.2|0.3|0.3
20+|13.3|13.7|13.5|Benign/Borderline|15624|106756918|Female|Meningioma|2006|14.4|14.9|14.6
20+|0.2|0.2|0.2|Malignant|242|106756918|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.0|14.2|14.1|Benign/Borderline|83267|540263219|Female|Meningioma|2006-2010|15.3|15.5|15.4
20+|0.2|0.2|0.2|Malignant|1054|540263219|Female|Meningioma|2006-2010|0.2|0.2|0.2
20+|13.6|14.0|13.8|Benign/Borderline|16575|110861505|Female|Meningioma|2007|14.7|15.2|15.0
20+|0.2|0.2|0.2|Malignant|260|110861505|Female|Meningioma|2007|0.2|0.3|0.2
20+|14.1|14.5|14.3|Benign/Borderline|17487|112086310|Female|Meningioma|2008|15.4|15.8|15.6
20+|0.1|0.2|0.2|Malignant|205|112086310|Female|Meningioma|2008|0.2|0.2|0.2
20+|14.7|15.1|14.9|Benign/Borderline|18565|113333902|Female|Meningioma|2009|16.1|16.6|16.4
20+|0.1|0.2|0.2|Malignant|196|113333902|Female|Meningioma|2009|0.1|0.2|0.2
20+|13.5|13.9|13.7|Benign/Borderline|17171|113527847|Female|Meningioma|2010|14.9|15.4|15.1
20+|0.1|0.2|0.1|Malignant|176|113527847|Female|Meningioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104421375|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|183|104421375|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105570557|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|226|105570557|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106756918|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|254|106756918|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|540263219|Female|Mixed glioma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Malignant|1194|540263219|Female|Mixed glioma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110861505|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|226|110861505|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112086310|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|248|112086310|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|113333902|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.2|Malignant|261|113333902|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|113527847|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|239|113527847|Female|Mixed glioma|2010|0.2|0.2|0.2
20+|0.5|0.6|0.6|Benign/Borderline|662|104421375|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|683|104421375|Female|Neoplasm, unspecified|2004|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|833|105570557|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|713|105570557|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|749|106756918|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|698|106756918|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|3831|540263219|Female|Neoplasm, unspecified|2006-2010|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|3347|540263219|Female|Neoplasm, unspecified|2006-2010|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|790|110861505|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|647|110861505|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|786|112086310|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|743|112086310|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|850|113333902|Female|Neoplasm, unspecified|2009|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|764|113333902|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.5|0.6|0.6|Benign/Borderline|710|113527847|Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|593|113527847|Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2330|104421375|Female|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|20|104421375|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2567|105570557|Female|Nerve sheath, benign and malignant|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|105570557|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2660|106756918|Female|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|106756918|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|12995|540263219|Female|Nerve sheath, benign and malignant|2006-2010|2.4|2.4|2.4
20+|0.0|0.0|0.0|Malignant|121|540263219|Female|Nerve sheath, benign and malignant|2006-2010|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2692|110861505|Female|Nerve sheath, benign and malignant|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|110861505|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2749|112086310|Female|Nerve sheath, benign and malignant|2008|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|25|112086310|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2798|113333902|Female|Nerve sheath, benign and malignant|2009|2.4|2.6|2.5
20+|~|~|~|Malignant|~|113333902|Female|Nerve sheath, benign and malignant|2009|~|~|~
20+|2.0|2.1|2.1|Benign/Borderline|2468|113527847|Female|Nerve sheath, benign and malignant|2010|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|21|113527847|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104421375|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|18|104421375|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105570557|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|21|105570557|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106756918|Female|Neuroepithelial|2006|~|~|~
20+|~|~|~|Malignant|~|106756918|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|540263219|Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|102|540263219|Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110861505|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|110861505|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112086310|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|26|112086310|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113333902|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|113333902|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113527847|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|113527847|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|143|104421375|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|104421375|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|170|105570557|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|105570557|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|176|106756918|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|106756918|Female|Neuronal/glial, neuronal|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|966|540263219|Female|Neuronal/glial, neuronal|2006-2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|91|540263219|Female|Neuronal/glial, neuronal|2006-2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|189|110861505|Female|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|110861505|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|188|112086310|Female|Neuronal/glial, neuronal|2008|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|112086310|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|113333902|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|113333902|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|232|113527847|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113527847|Female|Neuronal/glial, neuronal|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|104421375|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|328|104421375|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105570557|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|336|105570557|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106756918|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|350|106756918|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|540263219|Female|Oligodendroglioma|2006-2010|~|~|~
20+|0.3|0.3|0.3|Malignant|1642|540263219|Female|Oligodendroglioma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110861505|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|354|110861505|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112086310|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|341|112086310|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113333902|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|336|113333902|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113527847|Female|Oligodendroglioma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|305|113527847|Female|Oligodendroglioma|2010|0.2|0.3|0.3
20+|0.0|0.1|0.1|Benign/Borderline|64|104421375|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|104421375|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|105570557|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|105570557|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|106756918|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|106756918|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|423|540263219|Female|Other mesenchymal|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|158|540263219|Female|Other mesenchymal|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|78|110861505|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|110861505|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|112086310|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|112086310|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|88|113333902|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|113333902|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|113527847|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|113527847|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104421375|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|118|104421375|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105570557|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|143|105570557|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106756918|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|138|106756918|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|540263219|Female|Pilocytic astrocytoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|684|540263219|Female|Pilocytic astrocytoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110861505|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|154|110861505|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112086310|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|112086310|Female|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113333902|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|122|113333902|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113527847|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|156|113527847|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104421375|Female|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|104421375|Female|Pineal parenchymal|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|105570557|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105570557|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|106756918|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|106756918|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|160|540263219|Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|114|540263219|Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|110861505|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|110861505|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|41|112086310|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|112086310|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|113333902|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|113333902|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|113527847|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|113527847|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3615|104421375|Female|Pituitary|2004|3.3|3.6|3.5
20+|0.0|0.0|0.0|Malignant|24|104421375|Female|Pituitary|2004|0.0|0.0|0.0
20+|3.8|4.1|3.9|Benign/Borderline|4151|105570557|Female|Pituitary|2005|3.8|4.1|3.9
20+|0.0|0.0|0.0|Malignant|23|105570557|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4559|106756918|Female|Pituitary|2006|4.1|4.4|4.3
20+|~|~|~|Malignant|~|106756918|Female|Pituitary|2006|~|~|~
20+|4.5|4.6|4.5|Benign/Borderline|24207|540263219|Female|Pituitary|2006-2010|4.4|4.5|4.5
20+|0.0|0.0|0.0|Malignant|49|540263219|Female|Pituitary|2006-2010|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4728|110861505|Female|Pituitary|2007|4.1|4.4|4.3
20+|~|~|~|Malignant|~|110861505|Female|Pituitary|2007|~|~|~
20+|4.4|4.6|4.5|Benign/Borderline|5018|112086310|Female|Pituitary|2008|4.4|4.6|4.5
20+|~|~|~|Malignant|~|112086310|Female|Pituitary|2008|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|5423|113333902|Female|Pituitary|2009|4.7|4.9|4.8
20+|~|~|~|Malignant|~|113333902|Female|Pituitary|2009|~|~|~
20+|4.4|4.6|4.5|Benign/Borderline|5053|113527847|Female|Pituitary|2010|4.3|4.6|4.5
20+|~|~|~|Malignant|~|113527847|Female|Pituitary|2010|~|~|~
20+|18.6|19.1|18.9|Benign/Borderline|20663|104421375|Female|Total|2004|19.5|20.1|19.8
20+|7.4|7.8|7.6|Malignant|8347|104421375|Female|Total|2004|7.8|8.2|8.0
20+|20.9|21.5|21.2|Benign/Borderline|23560|105570557|Female|Total|2005|22.0|22.6|22.3
20+|7.5|7.8|7.7|Malignant|8553|105570557|Female|Total|2005|7.9|8.3|8.1
20+|21.8|22.3|22.0|Benign/Borderline|24827|106756918|Female|Total|2006|23.0|23.5|23.3
20+|7.4|7.7|7.6|Malignant|8556|106756918|Female|Total|2006|7.8|8.2|8.0
20+|22.7|22.9|22.8|Benign/Borderline|131232|540263219|Female|Total|2006-2010|24.2|24.4|24.3
20+|7.3|7.5|7.4|Malignant|42873|540263219|Female|Total|2006-2010|7.9|8.0|7.9
20+|22.0|22.5|22.2|Benign/Borderline|26104|110861505|Female|Total|2007|23.3|23.8|23.5
20+|7.3|7.7|7.5|Malignant|8834|110861505|Female|Total|2007|7.8|8.1|8.0
20+|22.8|23.3|23.1|Benign/Borderline|27491|112086310|Female|Total|2008|24.2|24.8|24.5
20+|7.3|7.6|7.5|Malignant|8963|112086310|Female|Total|2008|7.8|8.2|8.0
20+|23.8|24.3|24.0|Benign/Borderline|29123|113333902|Female|Total|2009|25.4|26.0|25.7
20+|7.2|7.5|7.4|Malignant|9029|113333902|Female|Total|2009|7.8|8.1|8.0
20+|22.0|22.5|22.2|Benign/Borderline|27005|113527847|Female|Total|2010|23.5|24.1|23.8
20+|6.9|7.2|7.1|Malignant|8719|113527847|Female|Total|2010|7.5|7.8|7.7
20+|2.1|2.3|2.2|Benign/Borderline|2330|104421375|Female|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|20|104421375|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2570|105570557|Female|Tumors of Cranial and Spinal Nerves|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|105570557|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2661|106756918|Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|106756918|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|13004|540263219|Female|Tumors of Cranial and Spinal Nerves|2006-2010|2.4|2.4|2.4
20+|0.0|0.0|0.0|Malignant|121|540263219|Female|Tumors of Cranial and Spinal Nerves|2006-2010|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2693|110861505|Female|Tumors of Cranial and Spinal Nerves|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|110861505|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2751|112086310|Female|Tumors of Cranial and Spinal Nerves|2008|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|25|112086310|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2801|113333902|Female|Tumors of Cranial and Spinal Nerves|2009|2.4|2.6|2.5
20+|~|~|~|Malignant|~|113333902|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
20+|2.0|2.1|2.1|Benign/Borderline|2470|113527847|Female|Tumors of Cranial and Spinal Nerves|2010|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|21|113527847|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|350|104421375|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.2|Malignant|6716|104421375|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.4
20+|0.4|0.4|0.4|Benign/Borderline|411|105570557|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|6821|105570557|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|443|106756918|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|6867|106756918|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.4
20+|0.4|0.4|0.4|Benign/Borderline|2270|540263219|Female|Tumors of Neuroepthelial Tissue|2006-2010|0.4|0.4|0.4
20+|6.0|6.1|6.1|Malignant|34721|540263219|Female|Tumors of Neuroepthelial Tissue|2006-2010|6.4|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|453|110861505|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7197|110861505|Female|Tumors of Neuroepthelial Tissue|2007|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|456|112086310|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.4|0.4
20+|5.9|6.2|6.1|Malignant|7207|112086310|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|478|113333902|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|5.9|6.2|6.1|Malignant|7334|113333902|Female|Tumors of Neuroepthelial Tissue|2009|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|497|113527847|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.4
20+|5.7|6.0|5.8|Malignant|7134|113527847|Female|Tumors of Neuroepthelial Tissue|2010|6.1|6.4|6.3
20+|3.5|3.8|3.6|Benign/Borderline|3797|104421375|Female|Tumors of Sellar Region|2004|3.5|3.8|3.6
20+|0.0|0.0|0.0|Malignant|24|104421375|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|4328|105570557|Female|Tumors of Sellar Region|2005|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|23|105570557|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4745|106756918|Female|Tumors of Sellar Region|2006|4.3|4.6|4.4
20+|~|~|~|Malignant|~|106756918|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|25215|540263219|Female|Tumors of Sellar Region|2006-2010|4.6|4.7|4.7
20+|0.0|0.0|0.0|Malignant|53|540263219|Female|Tumors of Sellar Region|2006-2010|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|4938|110861505|Female|Tumors of Sellar Region|2007|4.3|4.6|4.5
20+|~|~|~|Malignant|~|110861505|Female|Tumors of Sellar Region|2007|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|5228|112086310|Female|Tumors of Sellar Region|2008|4.5|4.8|4.7
20+|~|~|~|Malignant|~|112086310|Female|Tumors of Sellar Region|2008|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5638|113333902|Female|Tumors of Sellar Region|2009|4.8|5.1|5.0
20+|~|~|~|Malignant|~|113333902|Female|Tumors of Sellar Region|2009|~|~|~
20+|4.5|4.8|4.7|Benign/Borderline|5269|113527847|Female|Tumors of Sellar Region|2010|4.5|4.8|4.6
20+|~|~|~|Malignant|~|113527847|Female|Tumors of Sellar Region|2010|~|~|~
20+|11.7|12.1|11.9|Benign/Borderline|13292|104421375|Female|Tumors of the Meninges|2004|12.5|12.9|12.7
20+|0.2|0.3|0.3|Malignant|293|104421375|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.1|13.6|13.3|Benign/Borderline|15127|105570557|Female|Tumors of the Meninges|2005|14.1|14.6|14.3
20+|0.2|0.3|0.3|Malignant|297|105570557|Female|Tumors of the Meninges|2005|0.3|0.3|0.3
20+|13.6|14.0|13.8|Benign/Borderline|15910|106756918|Female|Tumors of the Meninges|2006|14.7|15.1|14.9
20+|0.2|0.3|0.2|Malignant|271|106756918|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.3|14.5|14.4|Benign/Borderline|84722|540263219|Female|Tumors of the Meninges|2006-2010|15.6|15.8|15.7
20+|0.2|0.2|0.2|Malignant|1217|540263219|Female|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
20+|13.8|14.2|14.0|Benign/Borderline|16856|110861505|Female|Tumors of the Meninges|2007|15.0|15.4|15.2
20+|0.2|0.3|0.2|Malignant|294|110861505|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|14.4|14.8|14.6|Benign/Borderline|17819|112086310|Female|Tumors of the Meninges|2008|15.7|16.1|15.9
20+|0.2|0.2|0.2|Malignant|252|112086310|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|14.9|15.4|15.2|Benign/Borderline|18867|113333902|Female|Tumors of the Meninges|2009|16.4|16.9|16.6
20+|0.2|0.2|0.2|Malignant|222|113333902|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|13.7|14.2|14.0|Benign/Borderline|17467|113527847|Female|Tumors of the Meninges|2010|15.2|15.6|15.4
20+|0.1|0.2|0.2|Malignant|208|113527847|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|878|104421375|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|689|104421375|Female|Unclassified Tumors|2004|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1088|105570557|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|719|105570557|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1038|106756918|Female|Unclassified Tumors|2006|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|703|106756918|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|1.0|1.0|1.0|Benign/Borderline|5865|540263219|Female|Unclassified Tumors|2006-2010|1.1|1.1|1.1
20+|0.5|0.6|0.5|Malignant|3384|540263219|Female|Unclassified Tumors|2006-2010|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1130|110861505|Female|Unclassified Tumors|2007|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|650|110861505|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1205|112086310|Female|Unclassified Tumors|2008|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|757|112086310|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.0|1.1|1.1|Benign/Borderline|1303|113333902|Female|Unclassified Tumors|2009|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|772|113333902|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.0|1.1|1.1|Benign/Borderline|1274|113527847|Female|Unclassified Tumors|2010|1.1|1.2|1.1
20+|0.4|0.5|0.4|Malignant|601|113527847|Female|Unclassified Tumors|2010|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|46|104421375|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|~|~|~|Malignant|~|104421375|Female|Unique astrocytoma variants|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|105570557|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|105570557|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|106756918|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|23|106756918|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|272|540263219|Female|Unique astrocytoma variants|2006-2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|105|540263219|Female|Unique astrocytoma variants|2006-2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|57|110861505|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|110861505|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|112086310|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|19|112086310|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|68|113333902|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|113333902|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|58|113527847|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|113527847|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|97519135|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|97519135|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|98707416|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|98707416|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|99938602|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|99938602|Male|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|65|506533467|Male|All other|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|506533467|Male|All other|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103846993|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|103846993|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|105077378|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105077378|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|106309806|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|106309806|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|106608980|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|106608980|Male|All other|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|97519135|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|644|97519135|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|98707416|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|659|98707416|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|99938602|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|664|99938602|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|506533467|Male|Anaplastic astrocytoma|2006-2010|~|~|~
20+|0.6|0.7|0.6|Malignant|3259|506533467|Male|Anaplastic astrocytoma|2006-2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103846993|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|651|103846993|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105077378|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|694|105077378|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106309806|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|676|106309806|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106608980|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|657|106608980|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|97519135|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|192|97519135|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|98707416|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|196|98707416|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|99938602|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|203|99938602|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|506533467|Male|Anaplastic oligodendroglioma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Malignant|887|506533467|Male|Anaplastic oligodendroglioma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103846993|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|176|103846993|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105077378|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|182|105077378|Male|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106309806|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|175|106309806|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106608980|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|173|106608980|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|97519135|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|605|97519135|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|98707416|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|603|98707416|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|99938602|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|608|99938602|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|506533467|Male|Astrocytoma, NOS|2006-2010|~|~|~
20+|0.5|0.6|0.6|Malignant|2840|506533467|Male|Astrocytoma, NOS|2006-2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|103846993|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|611|103846993|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|105077378|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|608|105077378|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106309806|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|561|106309806|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|106608980|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|562|106608980|Male|Astrocytoma, NOS|2010|0.5|0.6|0.5
20+|0.0|0.0|0.0|Benign/Borderline|22|97519135|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|97519135|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|36|98707416|Male|Choroid plexus|2005|0.0|0.1|0.0
20+|~|~|~|Malignant|~|98707416|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|99938602|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|99938602|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|134|506533467|Male|Choroid plexus|2006-2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|506533467|Male|Choroid plexus|2006-2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|103846993|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103846993|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|105077378|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105077378|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|106309806|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106309806|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|106608980|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106608980|Male|Choroid plexus|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|175|97519135|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|97519135|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|98707416|Male|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|98707416|Male|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|174|99938602|Male|Craniopharyngioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|99938602|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|878|506533467|Male|Craniopharyngioma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|506533467|Male|Craniopharyngioma|2006-2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|180|103846993|Male|Craniopharyngioma|2007|0.1|0.2|0.2
20+|~|~|~|Malignant|~|103846993|Male|Craniopharyngioma|2007|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|183|105077378|Male|Craniopharyngioma|2008|0.1|0.2|0.2
20+|~|~|~|Malignant|~|105077378|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|188|106309806|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106309806|Male|Craniopharyngioma|2009|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|106608980|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106608980|Male|Craniopharyngioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|97519135|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|130|97519135|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|98707416|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|131|98707416|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|99938602|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|161|99938602|Male|Diffuse astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|506533467|Male|Diffuse astrocytoma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Malignant|811|506533467|Male|Diffuse astrocytoma|2006-2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103846993|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|167|103846993|Male|Diffuse astrocytoma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105077378|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|170|105077378|Male|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106309806|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|180|106309806|Male|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106608980|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|153|106608980|Male|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|97519135|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|91|97519135|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|98707416|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|98|98707416|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|99938602|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|91|99938602|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|506533467|Male|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|561|506533467|Male|Embryonal/primitive/medulloblastoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103846993|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|121|103846993|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105077378|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|121|105077378|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106309806|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|129|106309806|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106608980|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|117|106608980|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|131|97519135|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|97519135|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|138|98707416|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|98707416|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|149|99938602|Male|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|99938602|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|682|506533467|Male|Ependymoma variants|2006-2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|506533467|Male|Ependymoma variants|2006-2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|136|103846993|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103846993|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|142|105077378|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105077378|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|138|106309806|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106309806|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106608980|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106608980|Male|Ependymoma variants|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|97519135|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|281|97519135|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|98707416|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|280|98707416|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|99938602|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|269|99938602|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|27|506533467|Male|Ependymoma/anaplastic ependymoma|2006-2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1432|506533467|Male|Ependymoma/anaplastic ependymoma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103846993|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|274|103846993|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105077378|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|307|105077378|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106309806|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|316|106309806|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106608980|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|294|106608980|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|20|97519135|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|40|97519135|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|98707416|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|51|98707416|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|99938602|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|41|99938602|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|128|506533467|Male|Germ Cell Tumors|2006-2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|250|506533467|Male|Germ Cell Tumors|2006-2010|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|103846993|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|75|103846993|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|105077378|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|105077378|Male|Germ Cell Tumors|2008|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|106309806|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|33|106309806|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|106608980|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|54|106608980|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|97519135|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5251|97519135|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|98707416|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5321|98707416|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|99938602|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.5|Malignant|5312|99938602|Male|Glioblastoma|2006|5.2|5.5|5.3
20+|~|~|~|Benign/Borderline|~|506533467|Male|Glioblastoma|2006-2010|~|~|~
20+|5.5|5.6|5.5|Malignant|27824|506533467|Male|Glioblastoma|2006-2010|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|103846993|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5698|103846993|Male|Glioblastoma|2007|5.3|5.6|5.5
20+|~|~|~|Benign/Borderline|~|105077378|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5886|105077378|Male|Glioblastoma|2008|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|106309806|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.6|5.5|Malignant|5841|106309806|Male|Glioblastoma|2009|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106608980|Male|Glioblastoma|2010|~|~|~
20+|5.2|5.5|5.4|Malignant|5835|106608980|Male|Glioblastoma|2010|5.3|5.6|5.5
20+|~|~|~|Benign/Borderline|~|97519135|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|406|97519135|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|98707416|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|421|98707416|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|99938602|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|435|99938602|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|41|506533467|Male|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2064|506533467|Male|Glioma malignant, NOS|2006-2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|103846993|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|446|103846993|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105077378|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.5|Malignant|454|105077378|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106309806|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|428|106309806|Male|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106608980|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|380|106608980|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.2|0.3|0.2|Benign/Borderline|230|97519135|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|97519135|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|268|98707416|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|98707416|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|260|99938602|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|99938602|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|1290|506533467|Male|Hemangioblastoma|2006-2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|506533467|Male|Hemangioblastoma|2006-2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|246|103846993|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103846993|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|280|105077378|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|105077378|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|255|106309806|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|106309806|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|278|106608980|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106608980|Male|Hemangioblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|97519135|Male|Hemangioma|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|97519135|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|177|98707416|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|98707416|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|208|99938602|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|99938602|Male|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|1478|506533467|Male|Hemangioma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Malignant|~|506533467|Male|Hemangioma|2006-2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|248|103846993|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103846993|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|301|105077378|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|105077378|Male|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|375|106309806|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|106309806|Male|Hemangioma|2009|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|389|106608980|Male|Hemangioma|2010|0.3|0.4|0.4
20+|~|~|~|Malignant|~|106608980|Male|Hemangioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|97519135|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|97519135|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|98707416|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|98707416|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|99938602|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|33|99938602|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|506533467|Male|Local Extensions from Regional Tumors|2006-2010|~|~|~
20+|0.0|0.0|0.0|Malignant|130|506533467|Male|Local Extensions from Regional Tumors|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103846993|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|21|103846993|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105077378|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|31|105077378|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106309806|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|25|106309806|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106608980|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|106608980|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|97519135|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|711|97519135|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|98707416|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|737|98707416|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|99938602|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|732|99938602|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|506533467|Male|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
20+|0.7|0.7|0.7|Malignant|3559|506533467|Male|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103846993|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|715|103846993|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105077378|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.7|Malignant|755|105077378|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|106309806|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|740|106309806|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106608980|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|712|106608980|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|4.9|5.2|5.1|Benign/Borderline|4554|97519135|Male|Meningioma|2004|4.5|4.8|4.7
20+|0.2|0.2|0.2|Malignant|163|97519135|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.4|5.7|5.6|Benign/Borderline|5081|98707416|Male|Meningioma|2005|5.0|5.3|5.1
20+|0.1|0.2|0.2|Malignant|149|98707416|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.7|6.0|5.8|Benign/Borderline|5407|99938602|Male|Meningioma|2006|5.3|5.6|5.4
20+|0.1|0.2|0.2|Malignant|144|99938602|Male|Meningioma|2006|0.1|0.2|0.1
20+|6.0|6.2|6.1|Benign/Borderline|29200|506533467|Male|Meningioma|2006-2010|5.7|5.8|5.8
20+|0.1|0.2|0.1|Malignant|687|506533467|Male|Meningioma|2006-2010|0.1|0.1|0.1
20+|5.7|6.0|5.8|Benign/Borderline|5671|103846993|Male|Meningioma|2007|5.3|5.6|5.5
20+|0.2|0.2|0.2|Malignant|176|103846993|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.0|6.3|6.2|Benign/Borderline|6145|105077378|Male|Meningioma|2008|5.7|6.0|5.8
20+|0.1|0.2|0.1|Malignant|143|105077378|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.3|6.6|6.4|Benign/Borderline|6504|106309806|Male|Meningioma|2009|6.0|6.3|6.1
20+|0.1|0.2|0.1|Malignant|135|106309806|Male|Meningioma|2009|0.1|0.2|0.1
20+|5.9|6.2|6.1|Benign/Borderline|6232|106608980|Male|Meningioma|2010|5.7|6.0|5.8
20+|0.1|0.1|0.1|Malignant|107|106608980|Male|Meningioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|97519135|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|273|97519135|Male|Mixed glioma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|98707416|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|309|98707416|Male|Mixed glioma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|99938602|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|341|99938602|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|506533467|Male|Mixed glioma|2006-2010|~|~|~
20+|0.3|0.3|0.3|Malignant|1620|506533467|Male|Mixed glioma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103846993|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|331|103846993|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105077378|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|309|105077378|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106309806|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|370|106309806|Male|Mixed glioma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106608980|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|315|106608980|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|0.5|0.6|0.5|Benign/Borderline|473|97519135|Male|Neoplasm, unspecified|2004|0.4|0.5|0.5
20+|0.6|0.8|0.7|Malignant|598|97519135|Male|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|599|98707416|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|588|98707416|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|584|99938602|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|553|99938602|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|2832|506533467|Male|Neoplasm, unspecified|2006-2010|0.5|0.6|0.6
20+|0.6|0.6|0.6|Malignant|2814|506533467|Male|Neoplasm, unspecified|2006-2010|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|561|103846993|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|568|103846993|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|577|105077378|Male|Neoplasm, unspecified|2008|0.5|0.6|0.5
20+|0.6|0.7|0.7|Malignant|620|105077378|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|583|106309806|Male|Neoplasm, unspecified|2009|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|631|106309806|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|571|106608980|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.5|Malignant|529|106608980|Male|Neoplasm, unspecified|2010|0.5|0.5|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2114|97519135|Male|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|97519135|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2462|98707416|Male|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|98707416|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2397|99938602|Male|Nerve sheath, benign and malignant|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|18|99938602|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|11761|506533467|Male|Nerve sheath, benign and malignant|2006-2010|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|105|506533467|Male|Nerve sheath, benign and malignant|2006-2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2480|103846993|Male|Nerve sheath, benign and malignant|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|20|103846993|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2448|105077378|Male|Nerve sheath, benign and malignant|2008|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|24|105077378|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2502|106309806|Male|Nerve sheath, benign and malignant|2009|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|21|106309806|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2311|106608980|Male|Nerve sheath, benign and malignant|2010|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|22|106608980|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|97519135|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|97519135|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|98707416|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|17|98707416|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|99938602|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|23|99938602|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|506533467|Male|Neuroepithelial|2006-2010|~|~|~
20+|0.0|0.0|0.0|Malignant|115|506533467|Male|Neuroepithelial|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103846993|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|31|103846993|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105077378|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|105077378|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106309806|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|20|106309806|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106608980|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|106608980|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|147|97519135|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|97519135|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|169|98707416|Male|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|98707416|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|175|99938602|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|99938602|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|934|506533467|Male|Neuronal/glial, neuronal|2006-2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|102|506533467|Male|Neuronal/glial, neuronal|2006-2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|175|103846993|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|103846993|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|204|105077378|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105077378|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|210|106309806|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|106309806|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|201|106608980|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106608980|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|97519135|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|436|97519135|Male|Oligodendroglioma|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|98707416|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|405|98707416|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|99938602|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|412|99938602|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|506533467|Male|Oligodendroglioma|2006-2010|~|~|~
20+|0.4|0.4|0.4|Malignant|2013|506533467|Male|Oligodendroglioma|2006-2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|103846993|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|415|103846993|Male|Oligodendroglioma|2007|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|105077378|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|382|105077378|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106309806|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|440|106309806|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106608980|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|427|106608980|Male|Oligodendroglioma|2010|0.4|0.4|0.4
20+|0.1|0.1|0.1|Benign/Borderline|78|97519135|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|97519135|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|69|98707416|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|98707416|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|99938602|Male|Other mesenchymal|2006|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|99938602|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|390|506533467|Male|Other mesenchymal|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|166|506533467|Male|Other mesenchymal|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|103846993|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|103846993|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|105077378|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|105077378|Male|Other mesenchymal|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|106309806|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|106309806|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.0|0.1|0.1|Benign/Borderline|67|106608980|Male|Other mesenchymal|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|106608980|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|97519135|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|138|97519135|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|98707416|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|147|98707416|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|99938602|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|147|99938602|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|506533467|Male|Pilocytic astrocytoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|675|506533467|Male|Pilocytic astrocytoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103846993|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|139|103846993|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|105077378|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|137|105077378|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106309806|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|126|106309806|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106608980|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|146|106608980|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|97519135|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|97519135|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|98707416|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|17|98707416|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|99938602|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|99938602|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|72|506533467|Male|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|83|506533467|Male|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103846993|Male|Pineal parenchymal|2007|~|~|~
20+|~|~|~|Malignant|~|103846993|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|105077378|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|105077378|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106309806|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106309806|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106608980|Male|Pineal parenchymal|2010|~|~|~
20+|~|~|~|Malignant|~|106608980|Male|Pineal parenchymal|2010|~|~|~
20+|3.1|3.3|3.2|Benign/Borderline|3046|97519135|Male|Pituitary|2004|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|18|97519135|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3355|98707416|Male|Pituitary|2005|3.3|3.5|3.4
20+|~|~|~|Malignant|~|98707416|Male|Pituitary|2005|~|~|~
20+|3.5|3.8|3.7|Benign/Borderline|3598|99938602|Male|Pituitary|2006|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|17|99938602|Male|Pituitary|2006|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|20149|506533467|Male|Pituitary|2006-2010|3.9|4.0|4.0
20+|0.0|0.0|0.0|Malignant|63|506533467|Male|Pituitary|2006-2010|0.0|0.0|0.0
20+|3.7|4.0|3.9|Benign/Borderline|3961|103846993|Male|Pituitary|2007|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|24|103846993|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.0|4.3|4.2|Benign/Borderline|4323|105077378|Male|Pituitary|2008|4.0|4.2|4.1
20+|~|~|~|Malignant|~|105077378|Male|Pituitary|2008|~|~|~
20+|4.1|4.3|4.2|Benign/Borderline|4478|106309806|Male|Pituitary|2009|4.1|4.3|4.2
20+|~|~|~|Malignant|~|106309806|Male|Pituitary|2009|~|~|~
20+|3.9|4.2|4.1|Benign/Borderline|4364|106608980|Male|Pituitary|2010|4.0|4.2|4.1
20+|~|~|~|Malignant|~|106608980|Male|Pituitary|2010|~|~|~
20+|11.8|12.3|12.1|Benign/Borderline|11221|97519135|Male|Total|2004|11.3|11.7|11.5
20+|10.6|11.0|10.8|Malignant|10147|97519135|Male|Total|2004|10.2|10.6|10.4
20+|13.2|13.7|13.5|Benign/Borderline|12724|98707416|Male|Total|2005|12.7|13.1|12.9
20+|10.6|11.1|10.8|Malignant|10291|98707416|Male|Total|2005|10.2|10.6|10.4
20+|13.5|14.0|13.7|Benign/Borderline|13229|99938602|Male|Total|2006|13.0|13.5|13.2
20+|10.4|10.9|10.6|Malignant|10312|99938602|Male|Total|2006|10.1|10.5|10.3
20+|14.2|14.4|14.3|Benign/Borderline|70691|506533467|Male|Total|2006-2010|13.9|14.1|14.0
20+|10.4|10.6|10.5|Malignant|52281|506533467|Male|Total|2006-2010|10.2|10.4|10.3
20+|13.6|14.1|13.9|Benign/Borderline|13955|103846993|Male|Total|2007|13.2|13.7|13.4
20+|10.4|10.8|10.6|Malignant|10772|103846993|Male|Total|2007|10.2|10.6|10.4
20+|14.3|14.8|14.6|Benign/Borderline|14925|105077378|Male|Total|2008|14.0|14.4|14.2
20+|10.5|10.9|10.7|Malignant|11032|105077378|Male|Total|2008|10.3|10.7|10.5
20+|14.7|15.2|15.0|Benign/Borderline|15562|106309806|Male|Total|2009|14.4|14.9|14.6
20+|10.2|10.6|10.4|Malignant|10983|106309806|Male|Total|2009|10.1|10.5|10.3
20+|14.0|14.5|14.2|Benign/Borderline|14980|106608980|Male|Total|2010|13.8|14.3|14.1
20+|9.8|10.2|10.0|Malignant|10643|106608980|Male|Total|2010|9.8|10.2|10.0
20+|2.1|2.3|2.2|Benign/Borderline|2114|97519135|Male|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|97519135|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2462|98707416|Male|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|98707416|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2398|99938602|Male|Tumors of Cranial and Spinal Nerves|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|18|99938602|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|11768|506533467|Male|Tumors of Cranial and Spinal Nerves|2006-2010|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|105|506533467|Male|Tumors of Cranial and Spinal Nerves|2006-2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2481|103846993|Male|Tumors of Cranial and Spinal Nerves|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|20|103846993|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2450|105077378|Male|Tumors of Cranial and Spinal Nerves|2008|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|24|105077378|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2504|106309806|Male|Tumors of Cranial and Spinal Nerves|2009|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|21|106309806|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2312|106608980|Male|Tumors of Cranial and Spinal Nerves|2010|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|22|106608980|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|407|97519135|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.8|9.2|9.0|Malignant|8534|97519135|Male|Tumors of Neuroepthelial Tissue|2004|8.6|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|474|98707416|Male|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|8.9|9.3|9.1|Malignant|8659|98707416|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|506|99938602|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.1|8.9|Malignant|8735|99938602|Male|Tumors of Neuroepthelial Tissue|2006|8.6|8.9|8.7
20+|0.5|0.5|0.5|Benign/Borderline|2561|506533467|Male|Tumors of Neuroepthelial Tissue|2006-2010|0.5|0.5|0.5
20+|8.8|8.9|8.8|Malignant|44446|506533467|Male|Tumors of Neuroepthelial Tissue|2006-2010|8.7|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|495|103846993|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.7|9.1|8.9|Malignant|9129|103846993|Male|Tumors of Neuroepthelial Tissue|2007|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|541|105077378|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9350|105077378|Male|Tumors of Neuroepthelial Tissue|2008|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|547|106309806|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.6|9.0|8.8|Malignant|9337|106309806|Male|Tumors of Neuroepthelial Tissue|2009|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|558|106608980|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|8.3|8.7|8.5|Malignant|9142|106608980|Male|Tumors of Neuroepthelial Tissue|2010|8.4|8.8|8.6
20+|3.3|3.5|3.4|Benign/Borderline|3221|97519135|Male|Tumors of Sellar Region|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|18|97519135|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|3569|98707416|Male|Tumors of Sellar Region|2005|3.5|3.7|3.6
20+|~|~|~|Malignant|~|98707416|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.7|4.0|3.8|Benign/Borderline|3772|99938602|Male|Tumors of Sellar Region|2006|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|18|99938602|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.1|4.2|4.2|Benign/Borderline|21027|506533467|Male|Tumors of Sellar Region|2006-2010|4.1|4.2|4.2
20+|0.0|0.0|0.0|Malignant|64|506533467|Male|Tumors of Sellar Region|2006-2010|0.0|0.0|0.0
20+|3.9|4.2|4.0|Benign/Borderline|4141|103846993|Male|Tumors of Sellar Region|2007|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|24|103846993|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.2|4.5|4.3|Benign/Borderline|4506|105077378|Male|Tumors of Sellar Region|2008|4.2|4.4|4.3
20+|~|~|~|Malignant|~|105077378|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.3|4.5|4.4|Benign/Borderline|4666|106309806|Male|Tumors of Sellar Region|2009|4.3|4.5|4.4
20+|~|~|~|Malignant|~|106309806|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.1|4.4|4.2|Benign/Borderline|4550|106608980|Male|Tumors of Sellar Region|2010|4.1|4.4|4.3
20+|~|~|~|Malignant|~|106608980|Male|Tumors of Sellar Region|2010|~|~|~
20+|5.2|5.5|5.4|Benign/Borderline|4862|97519135|Male|Tumors of the Meninges|2004|4.8|5.1|5.0
20+|0.2|0.2|0.2|Malignant|189|97519135|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.8|6.1|5.9|Benign/Borderline|5418|98707416|Male|Tumors of the Meninges|2005|5.3|5.6|5.5
20+|0.2|0.2|0.2|Malignant|182|98707416|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.0|6.3|6.2|Benign/Borderline|5729|99938602|Male|Tumors of the Meninges|2006|5.6|5.9|5.7
20+|0.2|0.2|0.2|Malignant|172|99938602|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
20+|6.4|6.5|6.4|Benign/Borderline|30880|506533467|Male|Tumors of the Meninges|2006-2010|6.0|6.2|6.1
20+|0.2|0.2|0.2|Malignant|866|506533467|Male|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
20+|6.0|6.3|6.2|Benign/Borderline|5999|103846993|Male|Tumors of the Meninges|2007|5.6|5.9|5.8
20+|0.2|0.2|0.2|Malignant|213|103846993|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.4|6.7|6.5|Benign/Borderline|6518|105077378|Male|Tumors of the Meninges|2008|6.1|6.4|6.2
20+|0.2|0.2|0.2|Malignant|185|105077378|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|6.6|6.9|6.8|Benign/Borderline|6855|106309806|Male|Tumors of the Meninges|2009|6.3|6.6|6.4
20+|0.1|0.2|0.2|Malignant|180|106309806|Male|Tumors of the Meninges|2009|0.1|0.2|0.2
20+|6.3|6.6|6.4|Benign/Borderline|6577|106608980|Male|Tumors of the Meninges|2010|6.0|6.3|6.2
20+|0.1|0.2|0.1|Malignant|138|106608980|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|0.6|0.7|0.7|Benign/Borderline|595|97519135|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Malignant|605|97519135|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|777|98707416|Male|Unclassified Tumors|2005|0.7|0.8|0.8
20+|0.6|0.8|0.7|Malignant|597|98707416|Male|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|794|99938602|Male|Unclassified Tumors|2006|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|563|99938602|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|4321|506533467|Male|Unclassified Tumors|2006-2010|0.8|0.9|0.9
20+|0.6|0.7|0.6|Malignant|2861|506533467|Male|Unclassified Tumors|2006-2010|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|810|103846993|Male|Unclassified Tumors|2007|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|575|103846993|Male|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|882|105077378|Male|Unclassified Tumors|2008|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|629|105077378|Male|Unclassified Tumors|2008|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|960|106309806|Male|Unclassified Tumors|2009|0.8|1.0|0.9
20+|0.6|0.7|0.7|Malignant|640|106309806|Male|Unclassified Tumors|2009|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|962|106608980|Male|Unclassified Tumors|2010|0.8|1.0|0.9
20+|0.5|0.6|0.6|Malignant|541|106608980|Male|Unclassified Tumors|2010|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|87|97519135|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|97519135|Male|Unique astrocytoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|101|98707416|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|16|98707416|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|125|99938602|Male|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|99938602|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|647|506533467|Male|Unique astrocytoma variants|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|138|506533467|Male|Unique astrocytoma variants|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|115|103846993|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|103846993|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|133|105077378|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|33|105077378|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|141|106309806|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|106309806|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|152|106608980|Male|Unique astrocytoma variants|2010|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|22|106608980|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|23|201940510|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|201940510|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|204277973|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|204277973|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|206695520|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|206695520|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|144|1046796686|Male and Female|All other|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|1046796686|Male and Female|All other|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|214708498|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|214708498|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|217163688|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|217163688|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|219643708|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|219643708|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|220136827|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|220136827|Male and Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1188|201940510|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1147|204277973|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1151|206695520|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Anaplastic astrocytoma|2006-2010|~|~|~
20+|0.5|0.6|0.5|Malignant|5719|1046796686|Male and Female|Anaplastic astrocytoma|2006-2010|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1171|214708498|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1183|217163688|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1160|219643708|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|1186|220136827|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|368|201940510|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|352|204277973|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|332|206695520|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Anaplastic oligodendroglioma|2006-2010|~|~|~
20+|0.1|0.2|0.1|Malignant|1562|1046796686|Male and Female|Anaplastic oligodendroglioma|2006-2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|325|214708498|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|343|217163688|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|316|219643708|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|293|220136827|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1153|201940510|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1130|204277973|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1114|206695520|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Astrocytoma, NOS|2006-2010|~|~|~
20+|0.5|0.5|0.5|Malignant|5167|1046796686|Male and Female|Astrocytoma, NOS|2006-2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1128|214708498|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1082|217163688|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1031|219643708|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1008|220136827|Male and Female|Astrocytoma, NOS|2010|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|58|201940510|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|201940510|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|73|204277973|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|204277973|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|64|206695520|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|206695520|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|356|1046796686|Male and Female|Choroid plexus|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|1046796686|Male and Female|Choroid plexus|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|84|214708498|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|214708498|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|70|217163688|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|217163688|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|219643708|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|219643708|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|77|220136827|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220136827|Male and Female|Choroid plexus|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|357|201940510|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|201940510|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|391|204277973|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|204277973|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|360|206695520|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|206695520|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1886|1046796686|Male and Female|Craniopharyngioma|2006-2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1046796686|Male and Female|Craniopharyngioma|2006-2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|390|214708498|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|214708498|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|393|217163688|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|217163688|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|403|219643708|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|219643708|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|402|220136827|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220136827|Male and Female|Craniopharyngioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|235|201940510|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|251|204277973|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|242|206695520|Male and Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Diffuse astrocytoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|1393|1046796686|Male and Female|Diffuse astrocytoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|280|214708498|Male and Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|287|217163688|Male and Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|318|219643708|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|299|220136827|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|158|201940510|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|179|204277973|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|160|206695520|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Embryonal/primitive/medulloblastoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|963|1046796686|Male and Female|Embryonal/primitive/medulloblastoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|209|214708498|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|206|217163688|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|230|219643708|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|186|220136827|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|232|201940510|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|201940510|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|253|204277973|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|204277973|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|284|206695520|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|206695520|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1231|1046796686|Male and Female|Ependymoma variants|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|1046796686|Male and Female|Ependymoma variants|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|244|214708498|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|214708498|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|248|217163688|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|217163688|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|243|219643708|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|219643708|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|255|220136827|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220136827|Male and Female|Ependymoma variants|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|551|201940510|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|568|204277973|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|547|206695520|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|55|1046796686|Male and Female|Ependymoma/anaplastic ependymoma|2006-2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|2858|1046796686|Male and Female|Ependymoma/anaplastic ependymoma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|558|214708498|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|612|217163688|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|643|219643708|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|570|220136827|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|35|201940510|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|201940510|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|204277973|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|204277973|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|206695520|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|206695520|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|279|1046796686|Male and Female|Germ Cell Tumors|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|297|1046796686|Male and Female|Germ Cell Tumors|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|214708498|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|80|214708498|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|217163688|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|217163688|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|219643708|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|219643708|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|220136827|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|220136827|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9164|201940510|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.6|4.5|Malignant|9321|204277973|Male and Female|Glioblastoma|2005|4.5|4.7|4.6
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9422|206695520|Male and Female|Glioblastoma|2006|4.5|4.7|4.6
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Glioblastoma|2006-2010|~|~|~
20+|4.4|4.5|4.4|Malignant|48723|1046796686|Male and Female|Glioblastoma|2006-2010|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|9998|214708498|Male and Female|Glioblastoma|2007|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10211|217163688|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10206|219643708|Male and Female|Glioblastoma|2009|4.6|4.7|4.6
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.4|4.3|Malignant|10232|220136827|Male and Female|Glioblastoma|2010|4.6|4.7|4.6
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|805|201940510|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|794|204277973|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|816|206695520|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|79|1046796686|Male and Female|Glioma malignant, NOS|2006-2010|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4052|1046796686|Male and Female|Glioma malignant, NOS|2006-2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|850|214708498|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|217163688|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|876|217163688|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|219643708|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|915|219643708|Male and Female|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|220136827|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|750|220136827|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|423|201940510|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|201940510|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|481|204277973|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|204277973|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|464|206695520|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|206695520|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2322|1046796686|Male and Female|Hemangioblastoma|2006-2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|1046796686|Male and Female|Hemangioblastoma|2006-2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|449|214708498|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|214708498|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|510|217163688|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|217163688|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|469|219643708|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|219643708|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|485|220136827|Male and Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220136827|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|333|201940510|Male and Female|Hemangioma|2004|0.1|0.2|0.2
20+|~|~|~|Malignant|~|201940510|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|429|204277973|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|204277973|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|489|206695520|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|206695520|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|3490|1046796686|Male and Female|Hemangioma|2006-2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Malignant|24|1046796686|Male and Female|Hemangioma|2006-2010|0.0|0.0|0.0
20+|0.2|0.3|0.3|Benign/Borderline|584|214708498|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|214708498|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|714|217163688|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|217163688|Male and Female|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|827|219643708|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|219643708|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|950|220136827|Male and Female|Hemangioma|2010|0.4|0.5|0.4
20+|~|~|~|Malignant|~|220136827|Male and Female|Hemangioma|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|201940510|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|43|204277973|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|50|206695520|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Local Extensions from Regional Tumors|2006-2010|~|~|~
20+|0.0|0.0|0.0|Malignant|236|1046796686|Male and Female|Local Extensions from Regional Tumors|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|46|214708498|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|217163688|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|49|219643708|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220136827|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1281|201940510|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1379|204277973|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1380|206695520|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|~|~|~
20+|0.6|0.6|0.6|Malignant|6783|1046796686|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006-2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.6|0.6|Malignant|1330|214708498|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1437|217163688|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1381|219643708|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1428|220136827|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|8.5|8.8|8.6|Benign/Borderline|17589|201940510|Male and Female|Meningioma|2004|8.6|8.8|8.7
20+|0.2|0.2|0.2|Malignant|434|201940510|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.5|9.8|9.6|Benign/Borderline|19918|204277973|Male and Female|Meningioma|2005|9.6|9.9|9.8
20+|0.2|0.2|0.2|Malignant|421|204277973|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|9.9|10.1|10.0|Benign/Borderline|21031|206695520|Male and Female|Meningioma|2006|10.0|10.3|10.2
20+|0.2|0.2|0.2|Malignant|386|206695520|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.3|10.5|10.4|Benign/Borderline|112467|1046796686|Male and Female|Meningioma|2006-2010|10.7|10.8|10.7
20+|0.2|0.2|0.2|Malignant|1741|1046796686|Male and Female|Meningioma|2006-2010|0.2|0.2|0.2
20+|10.0|10.2|10.1|Benign/Borderline|22246|214708498|Male and Female|Meningioma|2007|10.2|10.5|10.4
20+|0.2|0.2|0.2|Malignant|436|214708498|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|10.4|10.7|10.5|Benign/Borderline|23632|217163688|Male and Female|Meningioma|2008|10.7|11.0|10.9
20+|0.1|0.2|0.2|Malignant|348|217163688|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|10.8|11.1|11.0|Benign/Borderline|25069|219643708|Male and Female|Meningioma|2009|11.3|11.6|11.4
20+|0.1|0.2|0.1|Malignant|331|219643708|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|10.0|10.3|10.2|Benign/Borderline|23403|220136827|Male and Female|Meningioma|2010|10.5|10.8|10.6
20+|0.1|0.1|0.1|Malignant|283|220136827|Male and Female|Meningioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|456|201940510|Male and Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|535|204277973|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|595|206695520|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Mixed glioma|2006-2010|~|~|~
20+|0.3|0.3|0.3|Malignant|2814|1046796686|Male and Female|Mixed glioma|2006-2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|557|214708498|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|557|217163688|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|631|219643708|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|554|220136827|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|0.5|0.6|0.6|Benign/Borderline|1135|201940510|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1281|201940510|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1432|204277973|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1301|204277973|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1333|206695520|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1251|206695520|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|6663|1046796686|Male and Female|Neoplasm, unspecified|2006-2010|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|6161|1046796686|Male and Female|Neoplasm, unspecified|2006-2010|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1351|214708498|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|1215|214708498|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1363|217163688|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1363|217163688|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1433|219643708|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1395|219643708|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.5|0.6|0.6|Benign/Borderline|1281|220136827|Male and Female|Neoplasm, unspecified|2010|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1122|220136827|Male and Female|Neoplasm, unspecified|2010|0.5|0.5|0.5
20+|2.1|2.2|2.2|Benign/Borderline|4444|201940510|Male and Female|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|201940510|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5029|204277973|Male and Female|Nerve sheath, benign and malignant|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|51|204277973|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5057|206695520|Male and Female|Nerve sheath, benign and malignant|2006|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|206695520|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|24756|1046796686|Male and Female|Nerve sheath, benign and malignant|2006-2010|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|226|1046796686|Male and Female|Nerve sheath, benign and malignant|2006-2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5172|214708498|Male and Female|Nerve sheath, benign and malignant|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|60|214708498|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|5197|217163688|Male and Female|Nerve sheath, benign and malignant|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|49|217163688|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5300|219643708|Male and Female|Nerve sheath, benign and malignant|2009|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|36|219643708|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.0|2.1|2.1|Benign/Borderline|4779|220136827|Male and Female|Nerve sheath, benign and malignant|2010|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|43|220136827|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|47|201940510|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|38|204277973|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|38|206695520|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|1046796686|Male and Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|217|1046796686|Male and Female|Neuroepithelial|2006-2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|51|214708498|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|44|217163688|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|41|219643708|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|50|220136827|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|290|201940510|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|201940510|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|339|204277973|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|204277973|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|351|206695520|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|39|206695520|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1900|1046796686|Male and Female|Neuronal/glial, neuronal|2006-2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|193|1046796686|Male and Female|Neuronal/glial, neuronal|2006-2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|364|214708498|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|45|214708498|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|392|217163688|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|217163688|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|415|219643708|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|36|219643708|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|433|220136827|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|220136827|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|764|201940510|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|741|204277973|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|762|206695520|Male and Female|Oligodendroglioma|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Oligodendroglioma|2006-2010|~|~|~
20+|0.3|0.4|0.4|Malignant|3655|1046796686|Male and Female|Oligodendroglioma|2006-2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|769|214708498|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|723|217163688|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|776|219643708|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|732|220136827|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|142|201940510|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|47|201940510|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|146|204277973|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|55|204277973|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|144|206695520|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|51|206695520|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|813|1046796686|Male and Female|Other mesenchymal|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|324|1046796686|Male and Female|Other mesenchymal|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|160|214708498|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|214708498|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|195|217163688|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|85|217163688|Male and Female|Other mesenchymal|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|184|219643708|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|68|219643708|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|220136827|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|220136827|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|201940510|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|256|201940510|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|204277973|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|290|204277973|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|206695520|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|285|206695520|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1046796686|Male and Female|Pilocytic astrocytoma|2006-2010|~|~|~
20+|0.1|0.1|0.1|Malignant|1359|1046796686|Male and Female|Pilocytic astrocytoma|2006-2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|214708498|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|293|214708498|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|217163688|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|281|217163688|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|219643708|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|248|219643708|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220136827|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|302|220136827|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|0.0|0.0|0.0|Benign/Borderline|23|201940510|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|201940510|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|204277973|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|204277973|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|42|206695520|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|206695520|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|232|1046796686|Male and Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|197|1046796686|Male and Female|Pineal parenchymal|2006-2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|214708498|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|214708498|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|217163688|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|217163688|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|219643708|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|219643708|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|220136827|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|220136827|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|6661|201940510|Male and Female|Pituitary|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|42|201940510|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|7506|204277973|Male and Female|Pituitary|2005|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|35|204277973|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|8157|206695520|Male and Female|Pituitary|2006|3.9|4.0|3.9
20+|0.0|0.0|0.0|Malignant|29|206695520|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.2|4.2|4.2|Benign/Borderline|44356|1046796686|Male and Female|Pituitary|2006-2010|4.2|4.3|4.2
20+|0.0|0.0|0.0|Malignant|112|1046796686|Male and Female|Pituitary|2006-2010|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8689|214708498|Male and Female|Pituitary|2007|4.0|4.1|4.0
20+|0.0|0.0|0.0|Malignant|32|214708498|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9341|217163688|Male and Female|Pituitary|2008|4.2|4.4|4.3
20+|~|~|~|Malignant|~|217163688|Male and Female|Pituitary|2008|~|~|~
20+|4.4|4.6|4.5|Benign/Borderline|9901|219643708|Male and Female|Pituitary|2009|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|20|219643708|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|9417|220136827|Male and Female|Pituitary|2010|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|20|220136827|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|15.5|15.8|15.7|Benign/Borderline|31884|201940510|Male and Female|Total|2004|15.6|16.0|15.8
20+|9.0|9.2|9.1|Malignant|18494|201940510|Male and Female|Total|2004|9.0|9.3|9.2
20+|17.4|17.8|17.6|Benign/Borderline|36284|204277973|Male and Female|Total|2005|17.6|17.9|17.8
20+|9.0|9.3|9.1|Malignant|18844|204277973|Male and Female|Total|2005|9.1|9.4|9.2
20+|18.0|18.3|18.1|Benign/Borderline|38056|206695520|Male and Female|Total|2006|18.2|18.6|18.4
20+|8.8|9.1|9.0|Malignant|18868|206695520|Male and Female|Total|2006|9.0|9.3|9.1
20+|18.7|18.9|18.8|Benign/Borderline|201923|1046796686|Male and Female|Total|2006-2010|19.2|19.4|19.3
20+|8.8|8.9|8.8|Malignant|95154|1046796686|Male and Female|Total|2006-2010|9.0|9.1|9.1
20+|18.1|18.5|18.3|Benign/Borderline|40059|214708498|Male and Female|Total|2007|18.5|18.8|18.7
20+|8.8|9.1|8.9|Malignant|19606|214708498|Male and Female|Total|2007|9.0|9.3|9.1
20+|18.9|19.3|19.1|Benign/Borderline|42416|217163688|Male and Female|Total|2008|19.3|19.7|19.5
20+|8.8|9.1|9.0|Malignant|19995|217163688|Male and Female|Total|2008|9.1|9.3|9.2
20+|19.6|19.9|19.8|Benign/Borderline|44685|219643708|Male and Female|Total|2009|20.2|20.5|20.3
20+|8.7|8.9|8.8|Malignant|20012|219643708|Male and Female|Total|2009|9.0|9.2|9.1
20+|18.3|18.6|18.4|Benign/Borderline|41985|220136827|Male and Female|Total|2010|18.9|19.3|19.1
20+|8.3|8.5|8.4|Malignant|19362|220136827|Male and Female|Total|2010|8.7|8.9|8.8
20+|2.1|2.2|2.2|Benign/Borderline|4444|201940510|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|201940510|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5032|204277973|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|51|204277973|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5059|206695520|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|206695520|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|24772|1046796686|Male and Female|Tumors of Cranial and Spinal Nerves|2006-2010|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|226|1046796686|Male and Female|Tumors of Cranial and Spinal Nerves|2006-2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5174|214708498|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|60|214708498|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5201|217163688|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|49|217163688|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5305|219643708|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|36|219643708|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.0|2.1|2.1|Benign/Borderline|4782|220136827|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|43|220136827|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Benign/Borderline|757|201940510|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15250|201940510|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.4|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|885|204277973|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.4|7.6|7.5|Malignant|15480|204277973|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|949|206695520|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|15602|206695520|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.4|7.7|7.5
20+|0.5|0.5|0.5|Benign/Borderline|4831|1046796686|Male and Female|Tumors of Neuroepthelial Tissue|2006-2010|0.4|0.5|0.5
20+|7.3|7.4|7.3|Malignant|79167|1046796686|Male and Female|Tumors of Neuroepthelial Tissue|2006-2010|7.5|7.6|7.6
20+|0.4|0.5|0.4|Benign/Borderline|948|214708498|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|7.3|7.6|7.4|Malignant|16326|214708498|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|997|217163688|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|16557|217163688|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1025|219643708|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
20+|7.2|7.4|7.3|Malignant|16671|219643708|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1055|220136827|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.5|0.5
20+|7.0|7.2|7.1|Malignant|16276|220136827|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.3|7.5|7.4
20+|3.4|3.5|3.5|Benign/Borderline|7018|201940510|Male and Female|Tumors of Sellar Region|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|42|201940510|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|3.9|3.9|Benign/Borderline|7897|204277973|Male and Female|Tumors of Sellar Region|2005|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|36|204277973|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|8517|206695520|Male and Female|Tumors of Sellar Region|2006|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|31|206695520|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.3|4.4|4.4|Benign/Borderline|46242|1046796686|Male and Female|Tumors of Sellar Region|2006-2010|4.4|4.5|4.4
20+|0.0|0.0|0.0|Malignant|117|1046796686|Male and Female|Tumors of Sellar Region|2006-2010|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|9079|214708498|Male and Female|Tumors of Sellar Region|2007|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|32|214708498|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.4|4.5|4.5|Benign/Borderline|9734|217163688|Male and Female|Tumors of Sellar Region|2008|4.4|4.6|4.5
20+|~|~|~|Malignant|~|217163688|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|4.6|4.7|4.6|Benign/Borderline|10304|219643708|Male and Female|Tumors of Sellar Region|2009|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|21|219643708|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9819|220136827|Male and Female|Tumors of Sellar Region|2010|4.4|4.5|4.5
20+|0.0|0.0|0.0|Malignant|20|220136827|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|8.8|9.1|8.9|Benign/Borderline|18154|201940510|Male and Female|Tumors of the Meninges|2004|8.9|9.1|9.0
20+|0.2|0.3|0.2|Malignant|482|201940510|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|9.8|10.1|9.9|Benign/Borderline|20545|204277973|Male and Female|Tumors of the Meninges|2005|9.9|10.2|10.1
20+|0.2|0.3|0.2|Malignant|479|204277973|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.1|10.4|10.3|Benign/Borderline|21639|206695520|Male and Female|Tumors of the Meninges|2006|10.3|10.6|10.5
20+|0.2|0.2|0.2|Malignant|443|206695520|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.6|10.8|10.7|Benign/Borderline|115602|1046796686|Male and Female|Tumors of the Meninges|2006-2010|11.0|11.1|11.0
20+|0.2|0.2|0.2|Malignant|2083|1046796686|Male and Female|Tumors of the Meninges|2006-2010|0.2|0.2|0.2
20+|10.3|10.5|10.4|Benign/Borderline|22855|214708498|Male and Female|Tumors of the Meninges|2007|10.5|10.8|10.6
20+|0.2|0.3|0.2|Malignant|507|214708498|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|10.7|11.0|10.9|Benign/Borderline|24337|217163688|Male and Female|Tumors of the Meninges|2008|11.1|11.3|11.2
20+|0.2|0.2|0.2|Malignant|437|217163688|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|11.1|11.4|11.3|Benign/Borderline|25722|219643708|Male and Female|Tumors of the Meninges|2009|11.6|11.9|11.7
20+|0.2|0.2|0.2|Malignant|402|219643708|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|10.3|10.6|10.5|Benign/Borderline|24044|220136827|Male and Female|Tumors of the Meninges|2010|10.8|11.1|10.9
20+|0.1|0.2|0.1|Malignant|346|220136827|Male and Female|Tumors of the Meninges|2010|0.1|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1473|201940510|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1294|201940510|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1865|204277973|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1316|204277973|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1832|206695520|Male and Female|Unclassified Tumors|2006|0.8|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1266|206695520|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|10186|1046796686|Male and Female|Unclassified Tumors|2006-2010|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|6245|1046796686|Male and Female|Unclassified Tumors|2006-2010|0.6|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1940|214708498|Male and Female|Unclassified Tumors|2007|0.9|0.9|0.9
20+|0.5|0.6|0.6|Malignant|1225|214708498|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2087|217163688|Male and Female|Unclassified Tumors|2008|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|1386|217163688|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2263|219643708|Male and Female|Unclassified Tumors|2009|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|1412|219643708|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.0|1.0|1.0|Benign/Borderline|2236|220136827|Male and Female|Unclassified Tumors|2010|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|1142|220136827|Male and Female|Unclassified Tumors|2010|0.5|0.5|0.5
20+|0.1|0.1|0.1|Benign/Borderline|133|201940510|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|201940510|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|139|204277973|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|204277973|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|169|206695520|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|206695520|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|919|1046796686|Male and Female|Unique astrocytoma variants|2006-2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|243|1046796686|Male and Female|Unique astrocytoma variants|2006-2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|172|214708498|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|44|214708498|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|187|217163688|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|52|217163688|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|209|219643708|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|219643708|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|210|220136827|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|220136827|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
